Establishment of transposon mutagenesis for Mycobacterium smegmatis by NGUYEN THUY KHANH
  
ESTABLISHMENT OF TRANSPOSON MUTAGENESIS 
FOR MYCOBACTERIUM SMEGMATIS 
 
 
NGUYEN THUY KHANH 
(B. Sc. (Hons), James Cook University) 
 
 
A THESIS SUBMITTED FOR THE DEGREE OF 
MASTER OF SCIENCE 
IN 
INFECTIOUS DISEASES, VACCINOLOGY AND DRUG DISCOVERY 
 
DEPARTMENT OF MICROBIOLOGY 
THE NATIONAL UNIVERSITY OF SINGAPORE 
AND 








I hereby declare that the thesis is my original work and it has been written by me in its 
entirety. I have duly acknowledged all the sources of information which have been used in 
the thesis. 
This thesis has also not been submitted for any degree in any university previously. 
 
_________________ 
Nguyen, Thuy Khanh  













I would like to express my deep thanks and gratitude to my supervisor Prof. Thomas Dick for 
his enthusiasm, guidance and patience throughout the year. Without his encouragement and 
support, I would never have reached the end! Also, very big thanks to Prof. Sebastien 
Gagneux for his kindness and willingness to be my co-supervisor.  
I sincerely thank the Novartis Institute for Tropical Diseases, Singapore for their critical 
financial support that has brought me the most exciting course in my life so far!  
I am particularly grateful to Mrs. Christine Mensch at Swiss TPH and Ms. Susie Soh Kah 
Wai at NUS for their excellent jobs in handling uncountable issues raised during the course to 
able to support me and my course-mates in the best possible way.  
Thanks all friends at Vietnam, Switzerland and Singapore. Especially to the six great course-
mates, Ankit, Boatema, Docars, Hana, Noemi and Varsha, who have helped and created a 
pleasant and wonderful working atmosphere during the time.  
I would also like to thank all members of DDL lab, importantly to Pooja and Jian Liang for 
their guidance, support and kindness.  
Finally, to my parents and family who have given me the strength and belief to achieve my 
goal. Thanks Mom for always understanding and sharing all my sadness and happiness. I 
could not have submitted this thesis without her support.  





Table of Contents 
Declaration…………………………………………………………………………………….i 
Acknowledgments…………………………………………………………………………….ii 
Table of contents……………………………………………………………………………...iii 
List of Tables………………………………………………………………………………….vi 
List of Figures………………………………………………………………………………..vii 





1.1.1. Mycobacterium tuberculosis……………………………………………………2 
1.1.2. Prevention, treatment and drug resistance of TB……………………………….3 
1.1.3. Development of drug-resistant tuberculosis…………………………………….4 
1.1.4. Understanding of the biology of M. tuberculosis for new drug targets……..….9 
1.2. Transposon mutagenesis……………………………………………………………10 
 1.2.1. Overview of transposons in bacteria…………………………………………..10 
 1.2.2. Transposon mutagenesis in mycobacteria……………………………………..20 
 1.2.3. The EZ-Tn5
 Transposome……………………………………………………..25 
1.3. Tuberculosis model – Mycobacterium smegmatis………………………………….26 
1.4. Aim of Project……………………………………………………………………….27 
 
2. MATERIALS AND METHODS………………………………………………………..28 
2.1. Bacterial strains, plasmids and media………………………………………………...28 
 2.1.1. Bacterial strains and plasmids…………………………………………………28 
iv 
 
 2.1.2. Bacterial culture media………………………………………………………...28 
 2.1.3. Glycerol stocks of bacteria………………………………………………….....30 
 2.1.4. Antibiotic preparation…………………………………………………………30 
2.2. General molecular methods……………………………………………………………30 
 2.2.1. Electroporation of M. smegmatis cells………………………………………...30 
 2.2.2. Small-scale preparation of mycobacterial genomic DNA……………………..32 
 2.2.3. Determination of DNA concentration and purity……………………………...35 
 2.2.4. Agarose gel electrophoresis…………………………………………………...36 
 2.2.5. Restriction enzyme digestion………………………………………………….37 
 2.2.6. Ligation of DNA fragments…………………………………………………...37 
 2.2.7. Polymerase chain reaction……………………………………………………..38 
2.2.8. Purification of DNA fragments from PCR amplification, restriction digestion 
and ligation reactions………………………………………………………...41 
 2.2.9. Southern blotting and hybridization…………………………………………...42 
 2.2.10. Electroporation of Escherichia coli cells…………………………………….49 
 2.2.11. Mini preparation of plasmid DNA…………………………………………...51 
 2.2.12. Sequencing of DNA………………………………………………………….52 
2.3. EZ-Tn5 transposon mutagenesis……………………………………………………...52 
 
3. RESULTS…………………………………………………………………………………56 
3.1. Generation of M. smegmatis transposon mutants…………………………………56 
 3.1.1. Optimization of M. smegmatis electroporation………………………………..56 
 3.1.2. Transposon mutagenesis of M. smegmatis using the EZ-Tn5 transposome…..58 
3.2. Optimization of isolation of M. smegmatis genomic DNA………………………..59 
3.3. Confirmation of the presence of transposon insertion in bacterial genome…….63 
v 
 
3.4. Confirmation of the single and random insertion by Southern hybridization….65 
3.5. Identification of transposon-disrupted gene by rescue cloning…………………..67 
 
4. DISCUSSION…………………………………………………………………………….73 
4.1. Isolation of mycobacterial genomic DNA………………………………………….73 
4.2. Transposon mutagenesis of M. smegmatis using the EZ-Tn5 transposome……..75 
4.3. Transposon-disrupted gene, pntB………………………………………………….78 




















List of Tables 
Table 1.1.  Use of transposon mutagenesis in mycobacterial studies……………………24 
Table 2.1.  Bacterial strains and plasmids used in the project……………………………28 
Table 2.2.  PCR Reaction Mixture Set Up……………………………………………….39 
Table 2.3.  PCR Cycling Conditions……………………………………………………..39 
Table 2.4.  Primers used in this study……………………………………………………40 
Table 2.5.  Southern blotting and Hybridization Solutions………………………………48 
Table 3.1.  Electroporation efficiency of M. smegmatis using pMV262………………...57 
Table 3.2.  Main differences in the preparation of mycobacterial genomic DNA  
       between the original and optimized methods………………………………...59 

















List of Figures 
Figure 1.1.  Colonial morphology and acid-fast stain of M. tuberculosis………………….2 
Figure 1.2.  Acquisition of drug resistance in M. tuberculosis……………………………..5 
Figure 1.3. Mechanisms of development of drug resistance in M. tuberculosis…………..6 
Figure 1.4.  Proposed epistatic interactions in drug-resistant M. tuberculosis complex…...8 
Figure 1.5.  Schematic diagram of some well-characterized transposons………………...12 
Figure 1.6.  Simplistic representation of cut-and-paste (A)  
and replicative (B) transpositions…………………………………………….14 
Figure 1.7.  Negative approach to identify essential genes……………………………….18 
Figure 1.8.  Positive approach to identify essential genes………………………………...20 
Figure 1.9.  Schematic representation of TraSH…………………………………………..22 
Figure 1.10.  Schematic representation of EZ-Tn5 Transposome………………………….26 
Figure 2.1.  Flow chart of steps involved for non-radioactive Southern blot……………..42 
Figure 2.2.  Schematic drawing of the Southern blot transfer “sandwich”……………….44 
Figure 2.3.  Photograph showing the Southern blot transfer “sandwich”………………...44 
Figure 2.4.  The process for rescue cloning of transposon insertion site in  
the genomic DNA using the EZ-Tn5 <R6Kγori/KAN-2> Transposome  
and EC100D pir
+
 E. coli cells………………………………………………..55 
Figure 3.1.  M. smegmatis transposon mutants generated by electroporation  
with the EZ-Tn5 <R6Kγori/KAN-2> transposome………………………….58 
Figure 3.2.  Agarose gel electrophoresis of M. smegmatis genomic DNA  
isolated using original and optimized methods………………………………61 
Figure 3.3.  Identify confirmation of M. smegmatis by PCR amplification………………63 
Figure 3.4.  Agarose gel electrophoresis of genomic DNA of  
M. smegmatis transposon mutants and wild type…………………………….64 
viii 
 
Figure 3.5.  Confirmation of the presence of transposon insertion in  
genome of M. smegmatis EZ-Tn5 <R6Kγori/KAN-2> mutants  
by PCR amplification of Kan
R
 gene………………………………………….64 
Figure 3.6.  Southern hybridization analysis showing random insertion of  
the EZ-Tn5 <R6Kγori/KAN-2> transposon into  
the chromosome of M. smegmatis……………………………………………66 
Figure 3.7.  Schematic diagram of the EZ-Tn5 <R6Kγori/KAN-2> transposon…………67 
Figure 3.8.  Restriction digest of transposon Mutant 1-generated plasmid……………….71 
Figure 3.9.  Mapping of transposon insertion and confirmation of  
Tn5 transposition in M. smegmatis transposon Mutant 1…………………….72 

















List of Abbreviations 
 
A260  Absorbance at wavelength of 260 nm 
A280  Absorbance at wavelength of 280 nm 
ADC  Albumin dextrose catalase 
AIDS  Acquired immunodeficiency syndrome 
Amp  Ampicillin 
Anti-DIG-AP Anti-digoxigenin alkaline phosphatase conjugate 
ATCC  American Type Culture Collection 
BCIP  5-bromo-4-chloro-3-indolyl phosphate 
BLAST Basic Local Alignment Search Tool 
BLASTN Nucleotide-nucleotide BLAST 
BLASTX Nucleotide 6-frame translation-protein BLAST 
bp  base pair 
BSA  Bovine serum albumin 
o
C  Celsius Degree 
c.f.u  Colony forming units 
CTAB  Cetyltrimethylammonium bromide 
DNA   Deoxyribonucleic acid 
DIG  Digoxigenin 
EB  Elution Buffer 
EDTA  Ethylenediaminetetraacetic acid 
g  Gram 
H2O  Water 
HCl  Hydrochloric acid 
HIV  Human immunodeficiency virus 
kb  kilobases 
KAN  Kanamycin 
Kan
R
  Kanamycin resistant 
L  Liter 
µF  Microfarad 
µg  Microgram 
µL  Microliter 
µM  Micromolar 
x 
 
mg  Milligram 
mL  Milliliter 
msec  Millisecond 
NAD  Nicotinamide adenine dinucleotide 
NADP  Nicotinamide adenine dinucleotide phosphate 
NaCl  Sodium chloride 
NaOH  Sodium hydroxide 
NBT  Nitroblue tetrazolium salt  
nm  nanometers 
Ω  Ohms 
OADC  Oleic acid dextrose albumin catalase 
OD600  Optical Density measured at wavelength of 600 nm 
PCR   Polymerase chain reaction 
RNA  Ribonucleic acid 
RNase  Ribonuclease 
rpm  Revolution per minute 
SDS  Sodium dodecyl sulphate 
SOC  Super Optimal Catabolite respression broth  
SSC  Saline-sodium citrate 
TBE  Tris borate EDTA 
TE (buffer) Tris EDTA  
TE  Transformation efficiency 
Tris  Tris (hydroxymethyl) aminomethane 
UV  Ultra-violet 











 Tuberculosis (TB) remains a major global health problem despite the availability of 
effective chemotherapy. This is largely a result of the emergence of drug-resistant strains of 
M. tuberculosis and the poor compliance of the long treatment of TB that requires therapy of 
multiple drugs. Thus, it is urgently needed to discover new targets for more effective anti-
mycobacterial drugs. In order to find new target, it is needed to understand the biology of the 
pathogen and function of its gene. Among new technologies, transposon mutagenesis is an 
excellent tool to dissect the genome of the organism for uncovering gene function. The non-
pathogenic and fast growing M. smegmatis is a commonly used model for surrogate-host 
genetic analysis of mycobacterial pathogens. The main aim of the project is to establish a 
transposon mutagenesis method for M. smegmatis mc
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Electroporation of 1 µL of the EZ-Tn5 <R6Kγori/KAN-2> transposome into the 
bacteria generated a total of 1.2 x10
3
 single kanamycin-resistant colonies. The small-scale 
preparation of M. smegmatis genomic DNA used in the project was a modification of a 
protocol employing only proteinase K, SDS and CTAB for disruption of the bacterial cells. 
The addition of lysozyme in the optimized method enhanced a considerable increase of more 
than 250% in the DNA yield compared to that of using the original protocol.  
The resistance to kanamycin, which is due to insertion of the Kan
R
 gene contained 
within the transposon in the genome of the bacteria, was confirmed by PCR amplification. In 
all randomly chosen M. smegmatis transposon mutants that were tested, the agarose gel 
electrophoresis of PCR products revealed a clear band of about 800 bp, indicating the 
presence of Kan
R
 gene that is 816 bp in size. The Southern hybridization analysis using 
labeled Kan
R
 gene as a probe has also proven that the transposon inserted only once per 
mutant clone and that it was randomly distributed in the genome.  
The rescue cloning method was used to locate the transposon insertion sites in the 
genome of three randomly selected mutants; however, it was successful for only one mutant. 
The transposon-disrupted gene in this mutant was identified as pntB, which is located at the 
locus MSMEG_0109. It has been shown that the pntB gene is highly conversed among 
Mycobacterium spp. and other species. However, this gene has not been involved in any 
studies of M. smegmatis based on a search for PubMed and Google Scholar. Thus, this is the 
first report of pntB as a non-essential gene in M. smegmatis.  
Transposon mutagenesis of M. smegmatis by the EZ-Tn5 transposome technology is a 
simple and efficient method to obtain transposon mutants. The established method described 
herein can be applied to generate large libraries of random gene knockouts in vivo of M. 
smegmatis, and other Mycobacterium species such as M. bovis BCG and M. abscessus, for 





1.1. Tuberculosis  
Tuberculosis (TB) is a common contagious infectious disease caused 
by several species of a closely related bacterial group known as the 
Mycobacterium tuberculosis complex (MTBC). M. tuberculosis is the best-
known member of MTBC as the main causative agent of human tuberculosis 
(Smith et al., 2009). The bacteria usually attack the lungs, but may spread to 
other parts of the body including kidney, spine and brain. They are transmitted 
through the air when people with active TB disease cough, sneeze or speak 
and therefore those nearby might breath in these bacteria and become infected 
(Centers for Disease Control and Prevention, 2012). However, healthy people 
who get infected with TB bacteria often do not become sick but exposure 
results in a latent infection. It is assumed that about one in ten latent infections 
eventually develops to active disease. If infected patients are not treated 
properly, the mortality rate for these active TB cases is more than 50% 
(Iseman & Madsen, 1989).  
According to the World Health Organization (WHO), TB remains a 
major global health problem. Two billion people are latently infected 
worldwide and approximately ten million people develop active disease 
annually, of which around two million die each year (WHO, 2010). In the 
1960s and 1970s, TB disappeared from the world public health agenda, but 
returned in the early 1990s for several reasons. These include the growing 
pandemic of HIV/AIDS and the emergence of drug-resistant strains (Lienhardt 




1.1.1. Mycobacterium tuberculosis  
M. tuberculosis, the main causative agent of tuberculosis, which was 
discovered by Robert Koch - a German physician - more than 100 years ago, 
is a relatively large, rod-shaped, non-motile and aerobic bacterium (Parish & 
Stroker, 1998). In addition, M. tuberculosis, like other mycobacteria, has an 
unusual cell wall structure (i.e. high lipids content, primarily mycolic acids). 
This makes them impervious to Gram-staining, but to Ziehl-Neelsen straining 
or acid-fast staining, so they are classified as acid-fast bacilli (Figure 1.1).  
M. tuberculosis takes around 18-20 hours for one cell division and 
about 2-4 weeks to form visible colonies. This is extremely slow compared to 
other bacteria whose division times can be measured in minutes, for example 
E. coli can divide around every 20 minutes (Parish & Stroker, 1998). It is also 
important to note that experimentation with M. tuberculosis requires biosafety 
level 3 (BSL-3) containment due to its high pathogenicity and potentially 
lethal effects for humans (Schwebach et al., 2001).  
 
  
Figure 1.1. Colonial morphology and acid-fast stain of M. tuberculosis 
Left: A close-up of a M. tuberculosis culture revealing this organism’s colonial 
morphology (Source: http://phil.cdc.gov/phil/details.asp?pid=4428)  
Right: M. tuberculosis bacteria stained red using acid-fast Ziehl-Neelsen stain 





1.1.2. Prevention, treatment and drug resistance of TB 
The vaccine bacilli Calmette-Guerin (BCG) developed by Albert 
Calmette and Camille Guerin a century ago can be used to prevent 
tuberculosis. The pathogenic bacterium M. bovis was passaged several 
hundred times leading to several gene deletions, and the eventual creation of 
the BCG vaccine (Bonah, 2005). The protective efficacy of BCG is variable; 
its effectiveness is about 70% in the United Kingdom whereas little or no 
protection against pulmonary TB was observed in South India. The vaccine 
can prevent severe forms of TB in children such as meningitis with more than 
80% effectiveness (Brandt et al., 2002). However, BCG vaccine is not able to 
prevent chronic infection or to protect against adult pulmonary TB, which 
accounts for most of the disease burden worldwide (Skeiky and Sadoff, 2006). 
Thus, antibiotics are used to treat TB disease.  
The current standard treatment for tuberculosis requires a multi-drug 
therapy comprising of rifampicin, isoniazid, pyrazinamide and ethambutol for 
two months. It is then continued with rifampicin and isoniazid for another four 
months (WHO, 2003). WHO has developed the DOST (Directly Observed 
Treatment Short Course) program by which the medicines would be taken 
under the supervision of medical supported staff to ensure patients take the 
combination of drugs correctly and regularly to reduce the risk of drug 
resistance (WHO, 2002). Nonetheless, drug-resistant tuberculosis is becoming 
increasingly prevalent. 
The past 20 years have seen the worldwide appearance of multidrug-
resistant (MDR) tuberculosis followed by extensively drug-resistant (XDR) 
tuberculosis, and most recently, appearance of strains that are resistant to all 
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anti-tuberculosis drugs (Gandhi et al., 2010). MDR tuberculosis is caused by 
the bacilli that are resistant to at least isoniazid and rifampicin, the two most 
effective and important first-line drugs against tuberculosis. XDR tuberculosis 
is defined as MDR tuberculosis that is additionally resistant to quinolones and 
also to any of the three injectable drugs, including kanamycin, capreomycin, 
and amikacin. As a result, drug resistance threatens to make TB incurable due 
to the possibility of a return to an era in which drugs are no longer effective 
(Raviglione, 2006). 
 
1.1.3. Development of drug-resistant tuberculosis  
Drug resistance in M. tuberculosis arises mainly through spontaneous 
mutations in the genome of the organism rather than as a result of horizontal 
gene transferring observed in most bacteria (David, 1970; Post et al., 2004). 
The acquisition of mutations in the chromosomal sequence depends on the 
mode of action of the drugs. For example, isoniazid kills bacteria by 
disrupting the cell wall synthesis. Isoniazid is a pro-drug needed to become 
activated to do its work. Mutations in katG have been shown to block 
activation of isoniazid.  
Similarly, mutation of rpoB confers resistance to rifampicin, a drug 
that is able to inhibit prokaryotic RNA synthesis (Chan & Iseman, 2008). The 





, respectively (David, 1970). Once resistant 
genotypes come into existence, drugs pressure would select the heritable 
types. By selection, drug-resistant bacteria multiply to become the dominant 
strain in the population (Post et al., 2004). An initial drug resistance has been 
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shown to cause treatment failure, and the resistance to additional drugs would 
facilitate resistance to several drugs (Figure 1.2) (Lew et al., 2008).  
 
 
Figure 1.2. Acquisition of drug resistance in M. tuberculosis  
(Gandhi et al., 2010) 
I=isoniazid, R=rifampicin, P=pyrazinamide, MDR TB = multidrug-resistant tuberculosis 
 
Figure 1.2 illustrates how isoniazid-resistant mutants are selected in a 
mono-therapy and are allowed to proliferate. Treatment of isoniazid-
monoresistant tuberculosis with isoniazid and rifampicin selects for 
spontaneous rifampicin-resistant mutants. This process is referred to as 
acquired resistance, the development of drug resistance during therapy by a 
strain that was originally drug sensitive (Gandhi et al., 2010).  
Drug-resistant M. tuberculosis strains can be also acquired de novo in 
individual patients undergoing TB treatment by two mechanisms: incorrect 
prescription or inappropriate and irregular intake of drugs of patients (Chan & 
Iseman, 2008). Treatment for other diseases can contribute to the acquired 
resistance. Widespread use of ﬂouroquinolones for respiratory tract and other 
infections, for example, might drive resistance to ﬂouroquinolones in 
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tuberculosis (Borrell & Gagneux, 2011). Once created, drug-resistant strains 
can spread through transmission to individuals who were never previously 
exposed to anti-tuberculosis drugs. This process is referred to as primary 
resistance (Figure 1.3).  
 
Figure 1.3. Mechanisms of development of drug resistance in M. tuberculosis 
(Gandhi et al., 2010) 
Patients with MDR-TB developed from drug-susceptible TB due to acquisition of 
resistance, i.e. acquired resistance, will be able to transmit the resistant strains to another 
person who was negative for TB. This mechanism is known as primary resistance. 
 
According to Gagneux et al. (2006), the spread of drug-resistant strains 
depends on competitive fitness. It means how well they grow compared to 
their drug-sensitive counterpart and how often they transmit in the population. 
As in other bacteria, resistance-conferring mutations that protect the MBTC 
against drugs generally carry a fitness “cost”. For example, the relative fitness 
of rifampicin-resistant mutants of TB from the laboratory is less than 1 (the 
equal fitness). This indicates that these mutant bacteria grow less well in 
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competition as compared with the drug susceptible strains (Gagneux et al., 
2006).  
However, if the mutants survive, they might by further genetic changes 
find a way to compensate for the initial fitness cost. This shows that the fitness 
cost varies depending on the specific conferring mutations. For instance, a 
certain kind of rifampicin-resistant mutants isolated from strains circulating in 
TB patients, e.g. rpoB S531 L mutation, has shown evidence to overcome the 
handicap. This strain is then more easily transmitted and, therefore more 
dangerous (Gagneux et al., 2006).  
The fitness cost affecting a specific resistance-conferring mutation can 
be modulated by the strain genetic background in which this mutation has 
occurred. Borrell & Gagneux (2009) have showed that both MDR and XDR 
tuberculosis are often co-infected with HIV. This demonstrates that drug-
resistant mutants might be less fit than the drug sensitive counterpart. In 
countries of the former Soviet Union, however, though the rates of HIV are 
low, the MDR strains of MTBC are highly successful. One explanation might 
be due to the fact that the drug-resistant strains have been circulating for a 
long time in these areas and the compensatory evolution has, therefore, 
occurred to lessen the initial fitness deficits (Borrell & Gagneux, 2009). 
Interestingly, the Beijing strains have been reported to have the most frequent 
association with drug resistance in these regions. This suggests that the strain 
genetic background might also have a role (Borrell & Gagneux, 2009).  
In a recent review, Borrell & Gagneux (2011) have suggested that the 
fitness effects of the initial acquisition of drug-resistance-conferring mutations 
(primarily causing the development of drug resistance in MTBC) could be 
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modulated by three factors. They include additional drug-resistance-
conferring-mutations, compensatory mutations (i.e. adaptations) and pre-
existing differences in strain genetic background. The interactions between 
these genetic factors are generally known as epistasis (Figure 1.4).  
 
Figure 1.4. Proposed epistatic interactions in drug-resistant M. tuberculosis 
complex (MTBC) 
Human-adapted MTBC consists of six main phylogenetic lineages. The genetic 
background of these strain lineages could interact differently with drug resistance-
conferring mutations. Similar interactions could occur between different drug resistance-
conferring mutations and compensatory mutations (Borrell & Gagneux, 2011). 
 
Interactions among beneficial mutations will lead to a positive 
epistasis, whereas interactions of deleterious mutations will result in a 
negative one. The evolution of drug-resistant tuberculosis, as a result, will be 
promoted by positive epistasis because of fitness cost minimization. In 
contrast, negative epistasis constrains the evolution by enhancing the cost 
(Borrell & Gagneux, 2011). It is evident that there are possible epistatic 
interactions between different isoniazid-resistance-conferring mutations and 
pre-existing differences in the genetic background of different lineages of 
MTBC, e.g. the Beijing family of strains (Hershberg et al., 2008; Borrell & 
Gagneux, 2009).  
As mentioned above, the katG gene encodes a catalase-peroxidase that 
helps converting isoniazid into its bioactive form. This protein also protects 
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the bacteria against oxidative stress. As a result, high resistance to isoniazid 
but attenuation in virulence has been observed in inactivated katG clinical 
strains. A study of a putative compensatory mutations related to isoniazid 
resistance has showed that inactivated katG MTBC strains acquired promoter 
mutations of the alkyl hydroperoxide reductase ahpC. This leads to the over-
expression of this protein that might compensate for the lack of detoxification 
through the inactivation of katG (Sherman et al., 1996). 
The strain diversity in the MTBC is, therefore, believed to have an 
important role in the global emergence of MDR and XDR tuberculosis, which 
depends primarily on the initial acquisition of drug-resistance-conferring 
mutations. In particular, the fitness effects of these mutations could be 
modulated by the epistasis interactions between genetic factors such as 
different drug resistance conferring mutations, compensatory mutations and 
the strain genetic background (Borrell & Gagneux, 2011). 
 
1.1.4. Understanding of the biology of M. tuberculosis for new drug 
targets 
Despite the availability of the BCG vaccine and effective 
chemotherapy, TB still remains a major public health problem. This is largely 
due to the concomitant occurrence of drug-resistant strains of M. tuberculosis 
and the HIV epidemic, and the poor compliance with the long treatment of TB 
that requires therapy with multiple drugs. Thus, there is an urgent need to 
discover new targets for more effective anti-mycobacterial drugs. In order to 
find new targets, it is needed to understand the biology of the pathogen. The 
genome sequence of an organism provides all the encoded genes of an 
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organism, including all potential drug targets. However, the genome contains a 
large number of conserved hypothetical genes and other genes of unknown 
function at cellular level. About 40% of genes found in of M. tuberculosis 
have no known function (Cole et al., 1998).  
Among new technologies, transposon mutagenesis is one of the most 
powerful techniques to dissect the genome of organisms for uncovering gene 
function. Transposon mutagenesis can generate large libraries of random 
mutants that can be analyzed en masse for the loss or impairment of a 
particular function (Beliaev, 2005). Transposon mutagenesis has been used 
extensively to identify essential genes required for optimal growth of 
mycobacteria (Sassetti et al., 2003; Sassestti & Rubin, 2003, Zhang et al., 
2012). Several antibiotics used in TB treatment target a surprisingly small 
number of essential functions in the cell. Thus, the identification of genes 
important for growth would provide new drug targets that could be active 
against drug-resistant strains (Sassetti & Rubin, 2003). 
 
1.2. Transposon mutagenesis 
1.2.1. Overview of transposons in bacteria 
Classification of transposable elements  
 Transposable elements, also known as “jumping genes”, are sequences 
of DNA that can move from one position in the genome to another. Since their 
discovery in maize by Barbara McClintock in 1950s, transposable elements 
have been widely found in prokaryotes and eukaryotes, including humans 
(Hayes, 2003). Transposable elements are diverse in size, structure, insertion 
specificity, and transposition mechanism. In bacteria, they are distinguished in 
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two major groups: insertion sequences and transposons (Beliaev, 2005) 
(Figure 1.5).  
Insertion sequences (IS), the simplest of transposable elements, are 
short DNA fragments that less than 2 kb in size. The IS molecules contain two 
copies of short terminally inverted nucleotide repeats sized approximately 10-
40 bp. These inverted repeats flank a gene, called transposase, which encodes 
a special DNA-binding protein for mediating the transposition (Beliaev, 
2005).  
The transposon (Tn) family, in contrast to the IS elements, is more 
complex in structure as they contain genes that code for antibiotic resistance 
or other properties in addition to those essential for transposition. Transposons 
are more than 5 kb in size and contain 30-40 bp inverted repeats at their ends. 
They usually generate a 5-bp duplication at the target DNA site during 
insertion (Vizvaryova & Valkova, 2004). Some transposons, such as Tn5 and 
Tn10, have the central region carrying markers flanked by a pair of IS 
molecules located in a direct or inverse orientation (Beliaev, 2005). Most 
transposons, such as Tn3, Tn5, modified Tn7, Tn10 are favored as genetic 













Figure 1.5. Schematic diagram of some well-characterized transposons 
(Hayes, 2003) 
The insertion sequence IS1 is included for comparison. Black arrows: genes involved in 
the transposition of elements. White arrows: auxiliary genes. Triangles: inverted repeat 
sequences. The locations of the IS10 and IS50 in the composite transposons Tn10 and 
Tn5, respectively, are shown.  
 
Beside bacteria-derived transposons, the temperate bacteriophages 
such as lambda (λ), Mu (μ) or its derivatives are also considered as 
transposable elements. They represent a separate group of transposons 
although their structure is more complex than that of a typical transposon 
(Beliaev, 2005). The value of Mu bacteriophage as a genetic tool is because it 
integrates at random site within the host genome. The Mu phage possesses a 
transpososome consisting of four Mu transposases proteins and two 
transposon right-end DNA segments for its transposition machinery. It is 
active only in the presence of Mg
2+ 
ions. Similar to most transposons of the Tn 
family, the transposition of Mu induces a direct 5-bp duplication of the target 
sequence at site of insertion (Choi, 2009).  
A new group of transposable elements has been developed based on 
the mariner transposons, which are widespread among eukaryotic organisms 
(Rubin et al., 1999). The first mariner element found in Drosophila 
mauritiana is a small DNA element of about 1300 bp in size encoding a single 
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protein (mariner transposases) flanked by 30 bp short inverted terminal 
repeats sequences (Lampe et al., 1996). Among mariner-derived transposons, 
Mos1 (from fruit fly Drosophila melanogaster) and Himar1 (from horn fly 
Haematobia irritans) have been shown to efficiently transpose in variety of 
bacteria in vivo. These two mariner-based elements show little sequence 
specificity for an arbitrary TA dinucleotide at the insertion site that is 
duplicated during transposition. This characteristic enables the transposon to 
insert into diverse genomes of distantly related organisms. As transposons of 
the marine family require no species-specific host factors for transposition, 
they have been widely utilized for random mutagenesis of both eukaryotes and 
prokaryotes (Lampe et al., 1999; Rubin et al., 1999; Vizvaryova & Valkova, 
2004). The mariner-derived transposons have been used as genetic tools in a 
variety of bacteria species including Gram-negative and Gram-positive 
bacteria, and mycobacteria (Choi, 2009).  
 
Mechanisms for transposition and transposon delivery systems 
In majority of prokaryotic transposons, there are two major 
mechanisms for transposition to occur: the conservative or cut-and-paste 
transposition, and the replicative transposition (Beliaev, 2005).  
In the cut-and-paste transposition, the transposon sequence is excised 
from the donor molecule and subsequently inserted at the target site without 
duplication (Figure 1.6A). The transposition proceeds by a sequence of steps. 
Firstly, the transposase protein binds to the ends of the transposon (i.e. the 
inverted repeat sequences) to bring these ends together in form of a synaptic 
complex. The DNA is then cleaved between the donor molecule and ends of 
the transposon to release the synaptic complex from its donor site. Next, the 
14 
 
synaptic complex captures the new target site, and strand transfer events occur 
to incorporate the transposon to the new site. The loss of transposase proteins 
is suggested to be facilitated by host machinery. A protease of the host is 
hypothesized to cleave the transposase proteins leading to missing base pairs 
at the insertion site and the host factors fill DNA gaps at the insertion and 
donor sites (Hayes, 2003). The gaps in general are 5 bp at either end of the 
integrated gaps, but 9 bp for Tn5 and Tn10 transposons (Reznikoff, 2003; 
Goryshin et al., 2000). This type of transposition is characteristic for Tn5, 
Tn10 and mariner transposons (Beliaev, 2005). 
 In replicative transposition, the process starts with a formation of a co-
integration of the donor molecule that harbors the transposon and the target 
replicon resulting in a concomitant duplication of the transposon (Figure 
1.6B). After that, the transposon-specific site-specific recombinase helps 
resolve the co-integration to regenerate the intact donor replicon and the target 
molecule. The target then possesses only one copy of the transposon. The 
Transposon Tn3, Mu and many IS employ this mechanism for their 
transposition (Hayes, 2003).  
  
Figure 1.6. Simplistic representation of cut-and-paste (A) and replicative (B) 
transpositions (Hayes, 2003) 
(A) Cut-and-paste mechanism: the tranposase protein (ovals) binds to the ends of the 
transposon (black arc) and form a synaptic complex (step 1). DNA cleavage releases the 
transposon (step 2), which captures the new target site (double lines) (step 3). Further 
strand exchange reactions integrate the transposon at the new site (step 4) 
(B) Replicative transposition: the donor that harbors the transposon and the target 
molecule co-integrate resulting in a concomitant duplication of the transposon (step 1). 
Action of recombinase resolves the co-integration form to regenerate the intact donor and 




The frequency of transposition is typically low for in vivo transposon 
integration. An efficient delivery system is therefore critical for a successful 
mutagenesis. A variety of delivery vehicles have commonly used including 
suicide phages and plasmids that are unable to replicate within the target 
strain, but have mobilization ability (Beliaev, 2005). The host specificity range 
restricts the use of phage delivery systems and it is not efficiently adapted for 
distantly related organisms, which are not sensitive to bacteriophage infection. 
In contrast, plasmid delivery systems are more versatile because of its ability 
to transfer to the host, i.e. conjugation, transformation or electroporation. 
Suicide plasmids can also be used in a broader range of hosts. In general, the 
choice of a useful transposon delivery vehicle largely depends on the target 
strain and on the transposition target (Beliaev, 2005). 
 
Transposons as tool for mutagenesis and its advantages 
Since transposons can cause different sequence rearrangements such as 
insertions, deletions and inversions, they have been used as highly useful tool 
to create random mutants for bacterial genetic studies. Transposon 
mutagenesis has been adapted using in vivo and in vitro approaches in a broad 
range of Gram-negative and Gram-positive bacteria, and Mycobacteria 
(Beliaev, 2005).  
For in vivo mutagenesis, an appropriate suicide delivery vehicle 
containing the transposon is introduced into the host strain by transformation. 
Following insertion of transposon into the target site and loss of the suicide 
vector, the mutants are selected by plating on a medium containing 
appropriate antibiotics resistance marker. The main advantage of this approach 
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is that the target organism does not have to be naturally competent. Therefore, 
the transposon carried on the suicide vector can be introduced into the host 
using different transformation methods, such as electroporation or 
conjugation. However, in vivo mutagenesis exhibits some limitations. These 
include the need of a suicide vector for introducing the transposon into the 
host and the transposase protein must be expressed in the host. Because the 
transposase is usually expressed in subsequent generations, this results in 
potential insertion instability (Goryshin & Rezinikoff, 1998).  
On the other hand, in vitro mutagenesis has been developed to bypass 
the inherent difficulty of using plasmid-mediated transfer of transposon 
sequences (Beliaev, 2005). In this approach, the reactions of strand-transfer 
between linear DNA molecules are catalyzed by purified transposase protein 
in a cell-free environment. The mutated DNA molecules are then introduced 
into the host by transformation (Goryshin et al., 2000). While the major 
advantage of the in vitro-based methods is the ability to reach high-saturation 
levels of mutagenesis, its distinct disadvantage is the prerequisite for 
preliminary information on the target sequence (Beliaev, 2005).  
Transposon mutagenesis offers several advantages over other 
techniques including chemical and physical mutagenesis (Siegrist & Rubin, 
2009). Firstly, mutant cells containing transposon insertions can be separated 
from wild type cells using an antibiotic marker encoded by the transposon. 
Secondly, while chemical mutagenesis produces small changes whose 
locations can be difficult to identify, transposons mark their sites of insertion 
allowing easy isolation. Thirdly, transposons can be constructed in order to 
cause only a single mutation in a target strain. Finally, even though 
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transposons generally interrupt genes into which they insert, they can be also 
engineered to have other useful properties such as the ability to form 
transcriptional or translational fusions (Siegrist & Rubin, 2009). 
 
Application of transposon mutagenesis in identification of essential genes 
Genes that are required for survival and growth of an organism under a 
certain environmental condition are defined as essential genes. However, a 
gene might not be essential in one tested condition, but essential in another. 
The gene mutants in these cases can be studied for their effects on survival 
and growth under an environmental condition of interest. Transposon 
mutagenesis that can generate large libraries of random mutants is considered 
as a powerful method for determining essential genes (Reznikoff & 
Winterberg, 2008).  
According to Judson & Mekalanos (2000), there are two ways for 
identification of essential genes: (1) the “negative” approach, which identifies 
regions of the genome that are not essential and presume everything else is 
essential; and (2) the “positive” approach, which identifies essential genes by 
generating a conditional mutation and observing the lethal phenotype under a 
defined condition.  
The obvious problem with identification of essential genes is that 
knockout mutations in these particular genes are lethal. To get around this 
limitation, the negative approach can be used. This method introduces a large 
number of viable transposon insertions to enable to presume the regions in 





Figure 1.7. Negative approach to identify essential genes (Beliaev, 2005) 
Left: Schematic diagram of transposon mutagenesis: The insertion of transposon within a 
coding region of a gene results in interruption of protein translation, usually destroying its 
function. Right: Global transposon mutagenesis: the whole bacterial genome is the target 
for transposon mutagenesis.  
 
If transposon insertion occurs within a coding region of a gene, the 
translation of its protein will be interrupted and usually its function is 
destroyed. Thus, mutants have survived under defined conditions are those 
with insertions in genes that do not play essential functions for growth under 
this condition. In other words, these genes are nonessential. Once a library of 
mutants is created, each insertion site is sequenced and mapped to a precise 
location within the genome. Genes with no transposon insertions recovered 
are, therefore, putatively defined essential (Judson & Mekalanos, 2000). 
This approach has been applied to Mycoplasma genitalium to identify 
nonessential genes in order to define the minimal genome required for 
viability under laboratory growth conditions. Because of its small size genome 
(580 kb), M. genitalium is an ideal candidate for this particular method. There 
are a total of 1354 distinct sites of insertion defined not lethal, and up to 350 
of the 480 protein-coding genes have been suggested potential essential genes 
in the genome of M. genitalium (Hutchison et al., 1999). The in vivo 
transposition approach has been improved by combining with high-density 
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microarrays to identify essential genes required for growth of mycobacteria 
under defined conditions. This new method is called transposon site 
hybridization (TraSH) and developed by Sassetti et al. (2001). Use of TraSH 
in mycobacteria studies will be discussed further in the next section. While the 
advantage of the negative approach is that it does not require a naturally 
competent organism, the major disadvantage is that essential genes cannot be 
defined unless saturation mutagenesis is approached. Therefore, it requires a 
large number of transposon insertions to reach saturation before any 
conclusion can be drawn (Judson & Mekalanos, 2000).  
In contrast to the negative method, the “positive” approach identifies 
directly genes that are essential by replacing the natural promoter of the gene 
with a transposon-localized inducible promoter (Figure 1.8). Insertion of a 
transposon that carries an outward-facing inducible promoter into the 
promoter region of the target gene creates a transcriptional fusion, where the 
inducible promoter replaces the function of the natural promoter. Thus, the 
growth or survival of the organism is dependent on the inducer if the gene is 
essential (Judson & Mekalanos, 2000).  
The positive method has an advantage over other methods that every 
gene identified is a gene of interest and genes that are not strictly essential can 
be examined further under other growth conditions. However, this approach 
has several drawbacks. The maximum expression levels produced by the 
inducible promoter might not be enough to overcome the inactivation of the 
natural promoter. In contrast, it might produce too high level of the basal 
expression to allow the identification of essential genes for which only small 





Figure 1.8. Positive approach to identify essential genes (Beliaev, 2005) 
Transposition with a transposon containing an outward-facing inducible promoter at one 
edge in the presence of the inducer results in many possible transposon insertions. The 
horizontal arrows signify possible insertion locations on the bacterial chromosome. 
Screening identifies insertions that disrupt the promoter region of an essential gene (gray 
arrow). The strain generated by such an insertion is dependent on the inducer for 
viability. The insertional junction is sequenced, allowing the identification of the 
downstream essential gene.  
 
 
1.2.2. Transposon mutagenesis in mycobacteria 
As a powerful tool for determining the roles of bacterial genes in 
various biological processes, transposon mutagenesis has also been used 
extensively in mycobacterial studies, including M. smegmatis, M. avium, M. 
marinum, M. bovis BCG, and especially the most important pathogen M. 
tuberculosis. In mycobacteria, different transposable elements have been 
developed for use, such as Tn5367 derived from M. smegmatis insertion 
sequence IS1096, the transposon system Tn522 modified from Staphylococcus 
aureus, the mariner-derived transposons and the MycoMarT7 transposon 




transposome, developed by the Epicentre
®
 (USA) has been applied in several 
mycobacterium studies (Hoffman, 2011). 
In 2001, Sassetti et al. introduced a new technique called Transposon 
Site Hybridization (TraSH) that combines transposon mutagenesis and 
microarray hybridization to screen for essential genes required for growth 
under different conditions. A large and diverse library of M. bovis BCG 
mutants was generated using a Himar1-based mariner transposon and efficient 
temperature-sensitive phage transduction system.  
After mutagenesis, the bacterial mutants were compared for growth on 
rich and minimal medium. Genomic DNA was extracted from the surviving 
colonies under both growth conditions. To identify the insertion sites, genomic 
DNA was used to produce labeled RNA (i.e. TraSH target) complementary to 
the chromosomal sequences immediately adjacent to each transposon. These 
targets were mixed and hybridized to an M. bovis BCG microarray containing 
a fragment of DNA derived from each predicted ORF in the genome. By 
comparing hybridization signals derived from both mutant pools, a set of 
genes required for growth of M. bovis BCG on a minimal, but not rich, 
medium was defined (Figure 1.9).  
Thus, TraSH has been proven to be particularly useful for identifying 
conditionally essential genes in mycobacteria, which have been difficult to 
study by conventional methods due to their slow growth and the lack of 





Figure 1.9. Schematic representation of TraSH (Sassetti et al., 2001) 
Chromosomal region encompassing genes A–C from six different mutant strains 
(rectangles) is shown. Each mutant carries a single transposon insertion (triangles) that 
disrupts the function of a gene. Pools of mutants are grown under two different selective 
conditions. Genes A and C are nonessential for growth. Gene B is essential only under 
growth condition 2, and mutants harboring insertions in this gene are lost from this pool 
(represented by light shading). TraSH target that is complementary to the chromosomal 
DNA flanking each transposon insertion is generated from the two pools, labeled with 
different fluorophores, and hybridized to a microarray. The DNA probes representing 
genes A and C on the microarray will hybridize to the target generated from both pools. 
However, the target representing gene B will only be present in the pool from growth 
condition 1. By measuring the ratio of the two fluorophores for each probe, differential 
gene requirements are detected. 
 
TraSH was later used to identify genes that are important for growth of 
M. tuberculosis under both in vitro and in vivo (i.e. during infection in a 
mouse model of tuberculosis) conditions by finding those genes that cannot 
sustain transposon insertions (Sassetti et al., 2003; Sassetti & Rubin, 2003). 
While a total of 614 genes required for optimal growth in in vitro condition 
have been defined, the bacteria only needs 194 genes to survive in vivo. 
Interestingly, some mutants that are predicted to grow poorly in vitro were 
overrepresented in the in vivo pool. This suggests that the increase in bacterial 
growth in vivo is balanced by a decrease in growth rate under other conditions 
(Sassetti & Rubin, 2003).  
In most recent study, however, Rubin’s group has showed that protein-
coding genes are not the only genetic elements required for the optimal growth 
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of M. tuberculosis. High-density transposon mutagenesis (Sassetti et al., 2001) 
coupled with deep sequencing, Illumina Genome Analyzer 2, was developed 
to perform a comprehensive assessment of M. tuberculosis’s genetic 
requirements for growth.  
Results have shown that the coding regions required for optimal 
growth include not only whole-gene regions, as expected, but also genes that 
contain both required and non-required domains. In addition, many non-
coding regions, including regulatory elements and non-coding RNAs are 
critical for mycobacterial growth (Zhang et al., 2012). 
It is also worth to note that although transposon mutagenesis generates 
mutants containing nonessential genes in defined conditions, it can be a useful 
tool to identify genes whose products may alter the drug target to allow drug 
binding, activate the drug, or may be involved in drug transport (Maus et al., 
2005). Mycobacterial mutants generated by transposon mutagenesis in several 
studies are shown to exhibit either drug hypersusceptibility or drug resistance, 
as well as to be involved in intracellular survival and triphenylmethane dye 
decolorization, e.g. malachite green and methyl violet. Some mycobacterial 
studies with transposon mutagenesis techniques and the outcome are 


















suicide plasmid pPR27 
Mutant showed increased susceptibility to singlet 
oxygen and poor growth in murine macrophages, 
demonstrating that can be used to study the 
function of M. tuberculosis genes involved in 
intracellular survival and replication. 





Mutants with insertions into pks12 and Maa2520 
were multiple drug susceptible, indicating Maa2520 
and psk12 are first genes to be linked by mutation 
to intrinsic drug resistance in M. avium complex 
(MAC) 





Mutant with insertion into mtrB resembled a 
naturally occurring red morphotypic variant in that 
it stained with Congo red, and was sensitive to 
multiple antibiotics, suggesting the two-component 
regulatory system mtrAB is required for 







Transposon and spontaneous M. smegmatis and M. 
tuberculosis capreomycin-resistant mutants showed 
that mutation of the tlyA gene confers capreomycin 
resistance in mycobacteria. 







Nine beta-lactam antibiotic-hypersusceptible 
transposon mutants: two with insertions into ponA2 
and dapB known to be involved with peptidoglycan 
biosynthesis, and the other seven mutants have 
insertions affecting novel genes. 






Mutants with insertions in fbiC and the predicted 
gene MSMEG_2392 were unable to decolorize 
malachite green and methyl violet, indicating these 
two genes are involved in triphenylmethane dye 
decolorization. 
(Guerra-Lopez 
et al., 2007) 
M. bovis BCG 
IS1096 with suicide 
plasmipPR32 
Mutant with an insertion of the transposon in front 
of the gene bcg0231, leading to a drastically 
increased resistance of BCG to ampicillin, 
streptomycin and chloramphenicol. Results also 
provided evidence that rv0194, the almost identical 
gene to bcg0231, encodes a novel multidrug efflux 













transposome, which combines both in vitro and in vivo 
manipulations, has been developed utilizing the Tn5 transposition system. 
This new technique involves the in vitro formation of a Tn5-derived 
transposon-hyperactive Tn5 transposase complex (the transposome) followed 
by introduction of the complex into the target cells by electroporation. Once in 
the cell, the transposome is catalytically activated when it encounters the Mg
2+
 
present in the cell cytoplasm. This leads to the random insertion of the 
transposon into the host’s genome. Transposition clones are selected by 
plating on medium containing the antibiotic for which the EZ-Tn5 transposon 
encodes resistance (Figure 1.10B) (Goryshin et al., 2000).   
The Tn5-derived transposon can be any sequence that is defined by 
two specific 19-bp inverted repeat sequences called mosaic ends (MEs). In 
other words, MEs are the only sequences required for transposase binding, and 
so any sequence between MEs becomes a transposon (Hoffman, 2011). The 
EZ-Tn5 transposons typically contain a selectable marker (e.g. antibiotic 
resistance gene) plus an origin of replication, allowing rapid selection of 
transposed cells (Kirby, 2007).  
Although the transposome is normally formed transiently during in 
vitro DNA during transposition, a stable transposome can be prepared and 
isolated in the absence of Mg
2+
 (Figure 1.10A). In addition, the randomness of 
transposition has been confirmed by Southern blot analyses of genomic DNA 
(Gyroshin et al., 2000). The location of EZ-Tn5 transposon can be determined 
by using a variety of methods such as the rescue cloning (Kirby, 2007) or the 
direct genomic DNA sequencing (Hoffman et al., 2000). 
The use of the EZ-Tn5 transposome for random mutagenesis has been 
reported for many Gram-negative and Gram-positive bacteria as well as 
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mycobacteria, and has even been used in the yeast Saccharomyces cerevisiae 
and the protozoan Trypanosoma brucei (Hoffman, 2011). The EZ-Tn5 
transposome provides an efficient and reliable method for generating a library 
of random gene knockouts in vivo. Because no suicide vectors or specific host 
factors are required and the lack of the transposon-borne transposase gene, 
which make it stable once inserted into the host genome, the EZ-Tn5 
transposome system might become an ideal and valuable tool for genetic 







Figure 1.10. Schematic representation of EZ-Tn5 Transposome 
(A) EZ-Tn5 Transposome is a stable complex by incubating an EZ-Tn5 Transposon with 
EZ-Tn5 Transposase in the absence of Mg
2+
  
(B) The EZ-Tn5 Transposome complex can be electroporated into living cells where it 
randomly inserts the transposon component into the host’s genomic DNA. The EZ-Tn5 
transposon insertion site can be analyzed by a variety of methods.  
 
1.3. Tuberculosis model – Mycobacterium smegmatis 
 M. smegmatis is a commonly used organism for genetic studies of 
mycobacteria because this strain is nonpathogenic, fast growing and DNA can 
be introduced into it by electroporation efficiently (Derbyshire et al., 2000). 
This species shares more than 2000 homologs with M. tuberculosis and has 
similar cell wall structure to that of M. tuberculosis and other mycobacterial 
species. The most popular M. smegmatis strain used in mycobacterial 
genetics, M. smegmatis mc
2
 155, is able to be cultured in most laboratory 
media. It has an average generation time of about 3 hours and forms visible 
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colonies in 3 to 5 days depending on the medium, and can be work on in 
Biosafety Level 1 laboratory (Singh & Reyrat, 2009). This particular strain, 
mc
2
 155, is hypertransformable and was originated from the reference strain 
ATCC 607 (Snapper et al., 1990).  
Thus, these properties (nonpathogenic, fast growing and 
hypertransformable) make M. smegmatis mc
2
 155 an attractive model for 
surrogate-host genetic analysis, e.g. transposon mutagenesis, of M. 
tuberculosis and other mycobacterial pathogens (Sassetti et al., 2001; Gao et 
al., 2003; Flores et al., 2005; Guerra-Lopez et al., 2007; Danilchanka et al., 
2008). 
 
1.4. Aim of project 
 In summary, TB remains a major global health problem despite the 
availability of effective chemotherapy. This is largely a result of the 
emergence of drug-resistant strains of M. tuberculosis and the poor 
compliance of the long treatment of TB that requires therapy of multiple 
drugs. Thus, it is urgently needed to discover new targets for more effective 
anti-mycobacterial drugs. In order to find new target, it is needed to 
understand the biology of the pathogen and function of its gene. Among new 
technologies, transposon mutagenesis is an excellent tool to dissect the 
genome of the organism for uncovering gene function. Furthermore, the non-
pathogenic and fast growing M. smegmatis is a commonly used model for 
surrogate-host genetic analysis of mycobacterial pathogens.  
 The main aim of the project is to establish a transposon mutagenesis 
method for M. smegmatis mc
2








2. Materials and methods 
2.1. Bacterial strains, plasmids and media 
2.1.1. Bacterial strains and plasmids 
The fast-growing Mycobacterium smegmatis mc
2 
155 was used as M. 
smegmatis wild type reference strain in the experiments. EC100D pir
+
 E. coli 
cells were used in rescue cloning and plasmid preparation experiments. The 
bacterial strains and plasmid vectors used in this study are listed in Table 2.1. 
 
Table 2.1. Bacterial strains and plasmids used in the project 
Strains/Plasmids Description Source 
Bacterial strains   
M. smegmatis mc2 155 Used as M. smegmatis wild type reference strain in the 
experiments 
Lab strain 
DH5α E. coli As electrocompetent cells for general cloning Lab strain 




Plasmids   
pMV262 KanR; used as positive control in electroporation of M. smegmatis Lab stock 
pJV53 KanR; used as positive control for PCR amplification of KanR Lab stock 
pBSSK AmpR; used as positive control in self-ligation reaction and as 
negative control in Southern blotting 
Lab stock 
pR6Kan KanR; used as positive control for PCR amplification of KanR, 




2.1.2. Bacterial culture media 
Luria-Bertani (LB) broth: 25 g of LB broth powder (Becton Dickinson, 
USA) was dissolved in 1 liter of Milli-Q water and mixed thoroughly by 
magnetic stirring. The solution was autoclaved at 121
o
C for 15 minutes. The 
medium was stored at 37
o
C for 2-3 days for checking contamination. If the 
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medium was not used immediately, it was prepared in aliquots of 50 mL and 
stored at 4
o
C until required.  
LB agar plates: 40g of LB agar powder (Becton Dickinson, USA) was 
dissolved in 1 liter of Milli-Q water and mixed thoroughly by magnetic 
stirring. The solution was autoclaved at 121
o
C for 15 minutes. The medium 
was cooled to 55
o
C and antibiotics (e.g. 50 µg/mL kanamycin or 100 µg/mL 
ampicillin) if required was added immediately prior to pouring into Petri 
dishes. Plates were allowed to set at room temperature, dried at 37
o
C 
overnight and stored at 4
o
C for later use.  
Middlebrook 7H9 broth: This liquid medium was used to culture 
mycobacteria. To 1 liter of medium, 4.7 g of the Middlebrook 7H9 powder 
(Becton Dickinson, USA) was dissolved in 900 mL of Milli-Q water 
containing 10 mL of 50% glycerol and 2.5 mL of 20% Tween 80. The adding 
of Tween 80 was in order to reduce cellular clumping. The solution was mixed 
thoroughly before subjected to autoclave at 121
o
C for 15 minutes. The 
medium was cooled to 55
o
C and 100 mL of ADC enrichment (Becton 
Dickinson, USA) was aseptically added. The medium was stored at 37
o
C for 
2-3 days for checking contamination. If the medium was not used 




Middlebrook 7H10 agar plates: This solid medium was used to isolate 
colonies of mycobacteria. To 1 liter of medium, 19 g of Middlebrook 7H10 
agar powder (Becton Dickinson, USA) was dissolved in 900 mL of Milli-Q 
water containing 10 mL of 50% glycerol. The solution was mixed thoroughly, 
autoclaved at 121
o
C for 15 minutes and cooled to 55
o
C. Supplement of 100 
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mL of OADC enrichment (Becton Dickinson, USA) and 25 µg/mL kanamycin 
if required was done immediately prior to pouring into plates. Plates were 
allowed to set at room temperature, dried at 37
o
C overnight and stored at 4
o
C 
for later use.  
2.1.3. Glycerol stocks of bacteria 
Glycerol stocks of bacteria were prepared by adding 500 µL of the 
late-log phase bacterial cultures (OD600 0.8 – 1.0) to an equal volume of sterile 
50% glycerol, mixed well and stored at -20
o
C.  
2.1.4. Antibiotic preparation 
Kanamycin (Sigma, USA) and ampicillin (Sigma, USA) stocks were 
prepared in distilled water at concentration of 50 mg/mL and 100 mg/mL, 
respectively. The antibiotic stocks were stored at -20
o
C until required. 
 
2.2. General molecular methods 
2.2.1. Electroporation of M. smegmatis cells 
Electroporations of M. smegmatis cells were performed as previously 
described by Goude and Parish (2009) with minor modifications.  
Typically, 100 μL of the glycerol stocks was used to inoculate 10 mL 
of fresh Middlebrook 7H9 broth in a T25 cell culture flask. Cultures were 
incubated at 37
o
C overnight on a rocker platform with gentle rocking. For 
subcultures, one mL of the preculture with OD600 of 0.5 to 0.7 was diluted 
with 100 mL of fresh 7H9 broth in a 250 mL conical flask. Incubation was 
done with slow shaking (100 rpm) in a shaker incubator at 37
o
C between 12 to 
16 hours (until OD600 of about 0.4 to 0.8). The cultures were immediately 
incubated on ice for 1.5 hours prior to harvesting. This step helps to increase 
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the transformation efficiency of M. smegmatis. However, it should be noted 
that incubation on ice for longer than 1.5 hours would result in a reduction in 
efficiency, most likely owing to excessive cell lysis. The bacterial cultures 
were subsequently transferred to two prechilled 50 mL Falcon Blue tubes. The 
bacterial cell pellets were harvested by centrifugation at 3000 rpm for 15 
minutes at 4
o
C on an Eppendorf centrifuge 5810R. The supernatant was 
carefully discarded and tubes were raised on tissue paper to drain. The pellets 
were then washed three times with ice-cold 10% glycerol and 0.05% Tween 
80 solution. Washing volumes were reduced each time.  
For the first wash, the two cell pellets were resuspended very gently in 
a total volume of 50 mL ice-cold 10% glycerol/Tween 80 solution and 
harvested by centrifugation at 3000 rpm for 15 minutes at 4
o
C. For the second 
wash, the pellets were resuspended in a total volume of 25 mL ice-cold 10% 
glycerol/Tween 80 solution. Cells were pooled in one 50 mL Falcon tube and 
harvested as above. After that, a third wash was performed by using 12.5 mL 
of ice-cold 10% glycerol/Tween 80 solution. The pellet was finally 
resuspended in 1 mL of ice-cold 10% glycerol/Tween 80 solution. The 
bacterial suspension was distributed in 200 μL aliquots which were then kept 
on ice for immediate electroporation or quickly frozen in liquid nitrogen prior 
to storage at -80
o





apparatus (Bio-Rad Laboratories) was used 
for electroporation experiments. Briefly, about 0.1 to 5 µg salt-free DNA in no 
more than 5 μL volume was added to 200 μL of cell suspension and mixed 
well by gentle pipetting. The cell/DNA mixture was left on ice for 10 minutes 




cuvettes (Bio-Rad Laboratories). The cuvettes were tapped on the counter to 
insure the cells are at the bottom of the cuvette. Before proceeding to 
electroporation, outside of the cuvette and inside of the electroporation 
chamber were dried as any liquid can cause malfunction and electric shock.  
The cuvette was then placed in the chamber and subjected to one 
single pulse set to 2.5 kV, capacity 25 µF and resistance 1000 Ω. After 
pulsing, the cuvette was removed from the chamber and 1 mL of 7H9 broth 
was immediately added to recover the cells. The cells suspension was 
resuspended quickly but gently. The cuvette was then placed back on ice for 
10 minutes and the cell suspension was transferred to a 50 mL Falcon Blue 
tube containing 4 mL of 7H9 broth and incubated at 37
o
C for 2 to 3 hours with 
shaking at 250 rpm to allow the cells to begin expressing antibiotic resistance 
genes. The pulse parameter was also checked and recorded. It has been 
suggested that the optimum time constant for M. smegmatis is 15 to 25 msec. 
Finally, 100 μL of the recovered bacterial culture with or without suitable 
dilution depending on the type of DNA samples (plasmid or transposon, 
respectively) were plated onto Middlebrook 7H10 agar containing appropriate 
antibiotic. Plates were incubated at 37
o
C until colonies became visible (2-3 
days). Transformants were counted to calculate the transformation efficiency. 
 
2.2.2. Small-scale preparation of mycobacterial genomic DNA  
Small-scale preparation of M. smegmatis wild type and transposon 
mutants genomic DNA were performed with a modified protocol from Belisle 
et al. (2009). 
Briefly, 200 μL of mycobacterial glycerol stocks were used to 
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inoculate 9.8 mL Middlebrook 7H9 broth in a T25 cell culture flask and 
incubated at 37
o
C overnight with gentle rocking. The 7H9 broth containing 
kanamycin at a final concentration of 25 µg/mL was used to grow transposon 
mutants. Five mL of the overnight cultures (OD600 of about 0.5 to 0.7) were 
transferred to a 15 mL Falcon Blue tube and harvested by centrifugation at 
3000 rpm for 15 minutes at room temperature. The supernatant was carefully 
discarded and cell pellet was resuspended in 500 μL of sterile water.  
The cells suspension was transferred to a new 1.5 mL microcentrifuge 
tube and quickly frozen in liquid nitrogen for 10 to 15 minutes or at -80
o
C for 
4 to 16 h. The freeze-thaw step is not required; however, it results in the 
weakening of the cell envelope and more efficient lysis of the cell. The 
bacterial suspension was heated at 95
o
C for 30 min to inactivate the cells and 
pelleted by centrifugation at 3000 rpm for 10 minutes at room temperature. 
The supernatant was discarded and the pellet was resuspended gently in 200 
μL of TE buffer (10mM Tris-Cl, pH 8.0; 1 mM EDTA). Next, 50 μL of 10 
mg/mL lysozyme solution (Merck) was added to the tube and mixed well by 
gentle pipetting. The tube was incubated at 37
o
C for 2 hours in a heating 
block. In the last 30 minutes of the incubation, 5 μL of 50 µg/mL RNase 
solution (Roche) was added to the cell mixture.  
Following this incubation, 200 μL of 10% (w/v) SDS (1st Base, 
Singapore) and 50 μL of 10 mg/mL proteinase K (Roche) was added to the 
cell mixture and incubated with slow shaking at 55
o
C for 1 hour in the 
thermomixer. At the end of the incubation, 100 μL of 5 M NaCl and 100 μL of 
10% CTAB which was preheated to 60
o
C (MP Biochemicals, USA) were 
added to the proteinase K-treated cell suspension and incubated at 60
o
C for 15 
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minutes with slow shaking. It is critical that the CTAB solution needs to be 
maintained at 60
o
C including while it is being added to the cell mixture as 
CTAB at 10% concentration will precipitate at room temperature. 
The cell mixture was then frozen at -80
o
C for 15 minutes, warmed to 
room temperature, incubated at 60
o
C with slow shaking for an additional 15 
minutes and frozen a final time at -20
o
C for 30 minutes to 16 hours. After 
subsequent freeze/thaw cycles, the cell lysate was warmed to room 
temperature followed by addition of an equal volume (700 μL) of chloroform: 
isoamyl alcohol (24:1) (Sigma). The tube was inverted 20 to 25 times until the 
organic and aqueous components mixed to form a homogenous white-opaque 
solution. Phase separation was achieved by centrifugation at 14000 rpm for 5 
minutes at room temperature and the aqueous phase was carefully transferred 
to a new 1.5 mL microcentrifuge tube. The chloroform: isoamyl alcohol 
extraction was repeated one more time using the previous aqueous phase. It is 
noted that at all aqueous phase collection steps, the aqueous phase should be 
removed as much as possible in a single pipetting to avoid any turbulence in 
the tube. A small amount of the aqueous phase should be remained, as 
removal all the way down to the organic layer will increase contamination 
with proteins dramatically.  
To precipitate the genomic DNA, 0.1 volume of 3 M sodium acetate 
(pH 5.2) and 1 volume of isopropanol were added to the aqueous extract. The 
tube was mixed by inverting slowly several times and placed at room 
temperature for at least 1 hour. The solution was centrifuged in a prechilled 
centrifuge at 14000 rpm for 30 minutes at 4
o
C to pellet the DNA. The 
supernatant was discarded carefully, and the DNA pellet was washed twice 
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with room- temperature 70% ethanol with centrifugation at 14000 rpm for 10 
minutes at 4
o
C between washes.  
The tube was left to dry on a 50
o
C heat block with lids open for 5 to 10 
minutes. It is important to not over dry the pellet because it will cause the 
genomic DNA difficult to redissolve. When all ethanol was just evaporated, 
the pellet was immediately resuspended in 100 μL of EB buffer (10 mM Tris-
Cl, pH 8.5, Qiagen) or TE buffer and incubated at 37
o
C with slow shaking for 
about 1 hour or at room temperature overnight and stored at -20
o
C until 
required. The concentration and purity of isolated genomic DNA was 
quantified using a spectrophotometer (Section 2.2.3) and the quality was 
monitored with 0.8% agarose gel electrophoresis (Section 2.2.4). 
 
2.2.3. Determination of DNA concentration and purity 
DNA concentration and purity were quantified using the nucleic acid 
setting on a NanoDrop ND-1000 spectrophotometer. The instrument was 
blanked with the same buffer the DNA sample being measured was dissolved 
in, and 1.5 μL of sample was used for each measurement. The concentration 
was calculated by the machine and displayed in ng/μL. The purity was 
determined by the ratio of absorbance of the DNA solution at 260 nm and 280 
nm (A260/A280 ratio), where a ratio of 1.8 indicates a high purity for double-
stranded DNA. An absorbance ratio of 1.7 to 2.0 is considered acceptable, 






2.2.4. Agarose gel electrophoresis 
Agarose gel electrophoresis was used to separate DNA fragments from 
polymerase chain reactions, restriction digests and genomic DNA isolated 
from cells. In general, a 0.8% agarose gel in 1x TBE buffer (0.09M Tris-
borate, 0.002M EDTA) was used unless otherwise indicated.  
Typically, a 0.8% agarose gel was prepared by dissolving 0.8 g 
agarose powder (Bio-Rad Laboratories) in 100 mL of 1x TBE buffer 
containing SYBR
®
 Safe DNA gel stain (Invitrogen) at a dilution of 1:10 000. 
The mixture was heated with stirring at 195
o
C on a hot magnetic stirrer until 
agarose was completely dissolved. The solution was checked to be clear 
without any visible gel pieces. The gel solution was cooled under tap water 
then poured into a casting tray and allowed to set (30 to 45 minutes at room 
temperature). The solidified gel was placed in an electrophoresis tank and 
submerged in 1x TBE buffer.  
Each sample was mixed with 0.2 volume of 6x DNA loading dye 
(Fermentas, Thermo Scientific) prior to loading into the wells. For each gel 
electrophoresis run, 5 μL of GeneRuler 1 kb DNA ladder (Fermentas, Thermo 
Scientific) was loaded into slots on both the right and left sides of the gel. 
Electrophoresis was performed at constant voltage of 85 V for 1.5 to 2 hours. 
The voltage is calculated based on the distance measured between the negative 
and positive electrodes of the gel tank that it is no more than 5 V/cm. The 
DNA fragments were visualized by exposing the gel to UV light in a UV 





2.2.5. Restriction enzyme digestion 
Total genomic DNA isolated from M. smegmatis wild type and 
transposon mutants was digested in a reaction containing 2 to 3 µg of DNA, 1 
µL (20 units) of restriction enzyme and with 5 µL of the recommended (10x) 
buffer. The reaction was made up to a final volume of 50 µL with autoclaved 
Milli-Q H2O. The mixture was mixed thoroughly, incubated at 37
o
C 
overnight, and stopped by heating at 65
o
C for 20 minutes.  
Plasmid DNA was typically digested with 10 units of restriction 
enzyme in a reaction containing 200 ng of DNA with 2 µL of the appropriate 
(10x) buffer. The reaction was made up to a final volume of 20 µL with 
autoclaved Milli-Q H2O. The mixture was mixed thoroughly, incubated at 
37
o
C for about 1 hour, and stopped by heating at 65
o
C for 20 minutes.  
The restriction digestion reaction mixture was separated by agarose gel 
electrophoresis (Section 2.2.4) or directly purified using the QIAquick PCR 
Purification Kit (Section 2.2.8) when required. Restriction enzymes used were 
EcoRI, HindIII and XhoI from New England Biolabs. In case where XhoI was 
used, the acetylated BSA was added and diluted to 1x in the final reaction 
mixture.  
 
2.2.6. Ligation of DNA fragments 
Self-ligation of fragmented genomic DNA and digested plasmid DNA 
was performed using Rapid DNA Ligation Kit according to manufacturer’s 
instructions (Roche). The standard ligation reaction was carried out in a 
reaction volume of 21 µL containing no more than 200 ng of DNA diluted in 
1x DNA dilution buffer to a final volume of 10 µL, 10 µL of (2x) T4 DNA 
38 
 
ligation buffer and 1 µL (5 units) of T4 DNA ligase. The mixture was mixed 
thoroughly and incubated for 5 minutes at room temperature. The ligation 
mixture was then purified using QIAquick PCR Purification Kit (Section 
2.2.8) prior to transformations into electrocompetent EC100D pir
+
 E. coli cells 
(Section 2.2.10).  
 
2.2.7. Polymerase chain reaction 
Polymerase chain reaction (PCR) was used to amplify specific 
products from genomic DNA, plasmid and ligation products. The PCR 
amplification was performed using the Phusion
TM 
High-Fidelity DNA 
Polymerase system (Finnzymes, Thermo Scientific) with reagents provided by 
the kit and according to the manufacturer’s recommendations. Reactions were 
set up on ice and run in a Biometra
® 
T3 Thermocycler. A typical PCR reaction 
mixture and cycling conditions were carried out as indicated in Table 2.2 and 
Table 2.3, respectively. Negative controls containing appropriate volume of 
RNase-free H2O instead of template DNA was used for every PCR. The 
primers used in this work were purchased from either Epicentre
®
 (USA) or 1
st
 
Base (Singapore), listed in Table 2.4. When the PCR reaction was completed, 
the products were separated and examined by agarose gel electrophoresis. The 
products of interest were also purified directly from the reaction mixture using 




Table 2.2. PCR Reaction Mixture Set Up 
Component Volume/reaction Volume/ reaction Final concentration 
RNase-free H2O Variable Variable  
5x Phusion HF or GF buffer 10 μL 4 μL 1x 
1 mM dNTPs 10 μL 4 μL 200 µM each 
Forward Primer [5 uM] 5 μL 2 μL 0.5 µM 
Reverse Primer [5 uM] 5 μL 2 μL 0.5 µM 
Template DNA† Variable Variable Template dependent 
Phusion DNA Polymerase* 0.5 μL 0. 2 μL 0.02 U/μL 
Total volume 50 μL 20 μL  
† General guidelines: between 50 – 250 ng for genomic DNA and 1 pg – 10 ng for plasmid DNA for 50 μL 
reaction. 
* Dilute polymerase with 1x reaction buffer to avoid pipetting errors 
 
 
Table 2.3. PCR Cycling Conditions 
Cycle step 
2-step protocol 3-step protocol 
Cycles 
Temp. Time Temp. Time 
Initial 
denaturation 



















15- 30 s/ 1 kb 
 
30 









† Annealing temperatures (Ta) required for use with Phusion tend to be higher than with other PCR 
polymerases. The NEB primer melting temperature Tm calculator http://www.neb.com/TmCalculator should be 
used to determine the Ta when using Phusion. When primers with Ta higher than 72
oC, two-step cycling without 
a separate annealing step can be used. 
* Generally, an extension time of 15 seconds per kb can be used. For complex amplicons, such as genomic 












Table 2.4. Primers used in this study 
 
 






Amplify upstream region of Ms-fadB2 
(MSMEG_0912, accession no. ABK71785) to 
confirm the identity of M. smegmatis mc2 155 
(Taylor et al., 2010) 
Ms-fadB2_RP CGGGATGCTCGACGTGTTCG 
KANR-FP ATGAGCCATATTCAACGGGAAACGT 
816 Amplify the Tn903 kanamycin resistance gene This study 
KANR-RP TTAGAAAAACTCATCGAGCATCAAA 
KAN-2 FP ACCTACAACAAAGCTCTCATCAACC 
- 
3’ end of the transposon (sequencing primer) 
Epicentre® (USA) 
R6KAN-2 RP CTACCCTGTGGAACACCTACATCT 
5’ end of the transposon (sequencing primer) 
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2.2.8. Purification of DNA fragments from PCR amplification, restriction 
digestion and ligation reactions 
DNA fragments were purified from PCR amplification, restriction 
digestion and ligation reactions for downstream work using the QIAquick
®
 
PCR Purification Kit (Qiagen) according to the manufacturer’s instructions. 
All centrifugation steps were carried out at 13000 rpm at room temperature. 
 Briefly, 5 volumes of buffer PB were added to 1 volume of the reaction 
mixture and thoroughly mixed by gently pipetting. The solution was applied to 
the QIAquick column and centrifuged for 1 minute. The flow-through was 
discarded and the column was washed by adding 750 µL of buffer PE. The 
washing buffer PE was allowed to incubate on the column for up to 5 minutes 
before centrifugation for 1 minute to more efficiently remove any salt from the 
DNA. The flow-through was discarded and the column was centrifuged for an 
additional 1 minute to remove residual wash buffer. The column was then 
placed in a clean 1.5 mL microcentrifuge tube and the bound DNA was eluted 
by adding 50 µL or 30 µL (for increased DNA concentration) of buffer EB (10 
mM Tris-Cl, pH 8.5) to the center of the membrane. The column was let to 
stand for 1 minute then centrifuged for a final time of 1 minute. However, it is 
noted that larger DNA fragments bind more tightly to the QIAquick columns. 
If the fragments are only a few kb larger than the 10 kb limit for the 
QIAquick
®
 PCR Purification Kit, the elution buffer EB should be heated to 
60
o
C and let incubated on the column for up 4 minutes before centrifuging to 





2.2.9. Southern blotting and hybridization  
Southern blotting was carried out to check for single copy and random 
distribution of the transposon insertion in the genome of M. smegmatis 
transposon mutants. The main steps of the Southern blot hybridization 
procedure are summarized in Figure 2.1 below. All steps were performed at 













Figure 2.1. Flow chart of steps involved for non-radioactive Southern blot 
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Preparation of template DNA 
Random labeling with DIG-dUTP 
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Gel electrophoresis and DNA blotting 
About 2-3 µg of M. smegmatis wild type and mutants genomic DNA 
were digested overnight with restriction enzyme EcoRI in a volume of 50 µL 
reaction (Section 2.2.5). The DNA fragments were separated by 0.8% agarose 
gel electrophoresis over 4 hours at a constant voltage of 40V. The gel was 
exposed to UV light to assess the efficiency of the restriction digestion 
reaction (Section 2.2.4).  
The gel was then placed in a plastic tray and completely covered with 
0.25 M HCl with gentle shaking, until the bromophenol blue marker was 
changed from blue to yellow (about 15 to 20 minutes). This acid depurination 
step is recommended when fragments larger than 10 kb are to be transferred. 
The acid solution was poured off and the gel was rinsed briefly with distilled 
water. The gel was next submerged in Denaturation solution for 30 minutes 
with gentle shaking. The solution was poured off and the gel was rinsed 
briefly with distilled water prior to subjecting to another 30 minutes with 
gentle shaking in Neutralization solution. Again, the solution was poured off 
and the gel was finally equilibrated in transfer buffer 20x SSC for at least 10 
minutes. While the gel was being treated before DNA transfer, a positively 
charged nylon membrane (Roche) cut to size of the gel was wet with 
autoclaved Milli-Q water and also allowed to equilibrate in transfer buffer 20x 
SSC for at least 10 minutes.  
The apparatus for Southern blot transfer was set up and DNA 
fragments were directly transferred from the agarose gel onto the positively 
charged nylon membrane by capillary action using high-salt transfer buffer 
20x SSC. Briefly, a support larger than the gel was placed in a plastic tray and 
covered with ten sheets of tissue papers. Two pieces of Whatman 3MM papers 
pre-soaked with 20x SSC were placed atop the support. The gel was then 
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placed upside-down atop the soaked Whatman 3MM papers. The gel was 
surrounded but not covered with plastic wrap or parafilm to ensure that the 
transfer buffer moved only through the gel and not around it. The wet nylon 
membrane was next placed on top of the gel. Any air bubbles were removed 
between membrane and gel by rolling a sterile pipette several times back and 
forth over the surface. Finally, another two pieces of dry Whatman 3MM 
papers, a stack of paper towel (20 cm), a glass or plastic plate, and a weight 
were placed on top of the membrane. The blot was allowed to transfer 
overnight in transfer buffer 20x SSC. The schematic drawing and photograph 
of the finished blot transfer “sandwich” are represented in Figure 2.2 and 
Figure 2.3, respectively.  
 
 
Figure 2.2. Schematic drawing of the Southern blot transfer “sandwich” 
 
Figure 2.3. Photograph showing the Southern blot transfer “sandwich” 
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After transfer, the membrane was incubated for 1 minute in 0.4 M 
NaOH to denature membrane-bounded DNA and then neutralized by 
incubating for 1 minute in 1x SSC/ 0.2 M Tris-Cl pH 7.5. The membrane was 
washed briefly in 2x SSC and dried on filter paper to avoid formation of salt 
crystals on the blot. The DNA was fixed by placing the membrane into a UV 
transilluminator that the DNA side was facing-down for about 10 minutes. The 
blot was rinsed with autoclaved Milli-Q water and the dried blot was stored 
between two filter papers in a sealed bag at 4
o
C for continuing or later use in 
the hybridization step. 
 
Probe preparation by random primed labeling 
Kanamycin resistance gene (Kan
R
) used as template to prepare the 
probe for Southern hybridization was purified from the PCR amplification of 
pR6Kan (Section 2.2.7). The PCR products were labeled with Digoxigenin 
(DIG)-11-dUTP alkali labile using the Random Primed DNA Labeling Kit 
(Roche), with reagents provided in the kit and according to the manufacturer’s 
recommendations. Firstly, about 1 µg of purified template DNA (top up to 
19.8 µL with autoclaved Milli-Q water in a 1.5 mL microcentrifuge tube) was 
denatured in a heat block for 10 minutes at 95
o
C. The tube was immediately 
chilled on ice for about 1 minute prior to other reagents were added into.  
A typical labeling reaction contained the following: 
Component Volume Final concentration 
Purified template DNA 19.8 μL 1 µg 
dNTP stock mix 4.5 μL 0.025 µM each for dATP, dCTP, dGTP 
DIG stock mix 1.2 μL 0.0125 µM each for DIG-dUTP and dTTP 
Reaction Mixture 3 μL 1x 
Klenow ezyme 1.5 μL 2U/µL 
Total volume 30 μL  
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The mixture was mixed well, span down briefly and incubated at 37
o
C for 20 
hours. The reaction was stopped by adding 2 µL of 0.2 M EDTA pH 8.0 
and/or by heating to 65
o
C for 10 minutes. The labeled DNA probes can be 
used immediately for hybridization or stored at -20
o
C until required.  
 
Hybridization 
During prehybridization, hybridization and detection steps, the 
membrane should not be allowed to dry, otherwise the assay would have a 
high background. For prehybridization, the membrane was placed in a clean 
plastic container containing approximate 30 mL of DIG Easy Hyb buffer 
(Roche), which was pre-warmed to the hybridization temperature (45
o
C). The 
container was carefully sealed with parafilm and incubated at 45
o
C with gentle 
agitation for about 4 hours.  
The DIG-labeled DNA probes were placed into a 1.5 mL 
microcentrifuge tube along with 50 µL of autoclaved Milli-Q water. The tube 
was heated at 95
o
C for 5 minutes to denature the probes and rapidly chilled on 
ice. The denatured probes were added to a Falcon tube containing 25 mL of 
pre-warmed DIG Easy Hyb buffer to a final concentration of 5-25 ng/mL. The 
mixture was mixed by gentle inversion to avoid foaming as bubbles may lead 
to background. The prehybridization buffer was poured off and the 
hybridization solution containing DIG-labeled probes was immediately added 
to the membrane. The container was again carefully sealed with parafilm and 
the hybridization was allowed to occur at 45
o





Washing and detection of blot 
Following overnight hybridization, the membrane was subjected to 
Stringency washing to remove unspecific bound. Briefly, the hybridization 
solution was poured off and the membrane was immediately placed to a fresh 
tray containing sufficient volume of Low Stringency buffer to completely 
cover the blot. The membrane was washed twice for 5 minutes each with 
gentle shaking and fresh Low Stringency buffer was used for the second wash. 
Following the Low Stringency wash, the membrane was washed twice with 
preheated High Stringency buffer at 65
o
C for 15 minutes each with gentle 
shaking.  
After the final stringency wash, the membrane was again transferred to 
a fresh clean tray and washed with 1x Washing buffer for 5 minutes at room 
temperature. To block non-specific binding sites, the membrane was then 
incubated for 1 hour (can be up to 3 hours) in 100 mL freshly prepared 
Blocking solution with shaking. The blocking solution was discarded, and 20 
mL of fresh Antibody solution was poured onto the blot and incubated for 30 
minutes with shaking. The membrane was next washed twice with 15 minutes 
each with 100 mL portions of 1x Washing buffer to remove excess antibodies. 
Lastly, the membrane was equilibrated for 4 minutes in 20 mL of Detection 
buffer.  
 
Probe-target hybrids visualizing by colorimetric reaction 
The Detection buffer was discarded and the membrane was transferred 
to a fresh clean tray. The membrane was covered completely with 10 mL of 
freshly prepared of Color Substrate solution and incubated in the dark, e.g. a 
drawer, and importantly not shaking during color development. The 
membrane could be exposed to light for short time periods to monitor the 
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color change. When the color reaction produced bands of the desired intensity, 
the reaction was stopped by with autoclaved Milli-Q water or 1x TE buffer. 
The result was then documented by photography.  
 
Table 2.5. Southern blotting and Hybridization Solutions 
Solution Chemical composition 
Depurination solution  0.25 M HCl 
Denaturation solution 0.4 M NaOH, 0.6 M NaCl 
Neutralization solution  1.5 M NaCl, 0.5 M Tris-Cl pH 7.5 
1 M Tri-Cl, pH 7.5 121 g Tris base in 800 mL of Milli-Q water. Adjust to 
pH 7.5 with concentrated HCl (~70 mL) and fill up to 
1 Liter with water. 
20x SSC 3M NaCl, 0.3M Sodium citrate. 2H2O. Adjust to pH 
7.0 with 1M HCl 
Low Stringency buffer 2x SSC, 0.1% SDS (filer sterilized) 
High Stringency buffer 0.5x SSC, 0.1 % SDS (filer sterilized) 
10x Maleic acid buffer 1 M Maleic acid, 1.5 M NaCl. Adjust to pH 7.5 with 
NaOH (solid) 
1x Washing buffer 1x Maleic acid buffer, 0.3% (v/v) Tween 20 
1x Detection buffer 0.1 M Tris-Cl, 0.1 M NaCl. Adjust to pH 9.5 
Blocking reagent  Dissolve Blocking reagent powder (Roche) in 1x 
Maleic acid buffer to a final concentration of 10% 
(w/v) with stirring then autoclave at 121
o
C for 15 
minutes. The solution stores at 4
o
C.  
Blocking solution, prepare fresh Dilute 10x Blocking reagent 1:10 with 1x Maleic acid 
buffer 
Antibody solution, prepare fresh Centrifuge Anti-DIG-AP for 5 minutes at 10000 rpm 
in the original vial prior to each use. Dilute 1: 5000 in 
Blocking solution 
Color substrate solution, prepare 
fresh 
200 µL of NBT/BCIP stock solution (yellow, clear 




2.2.10. Electroporation of Escherichia coli cells  
The preculture was prepared by inoculating 5 mL of LB broth with 1 
μL of EC100D pir+ E. coli glycerol stocks in a 50 mL Falcon tube. The tube 
was incubated at 37
o
C with shaking at 200 rpm overnight.  For subcultures, 
one mL of the preculture was used to inoculate 100 mL of LB broth in a 1 
Liter conical flask. The flask was incubated at 37
o
C with vigorous shaking 
(250 rpm) between 1.5 to 2 hours (until the OD600 was about 0.4 - 0.7). The 
cultures were immediately incubated on ice for 15 minutes. For all subsequent 
steps, cells were to be kept close to 0
o
C and chilled all containers in ice before 
adding cells.  
The bacterial cultures were transferred into two prechilled 50 mL 
Falcon Blue tubes and cells were harvested by centrifugation at 3000 rpm for 
15 minutes at 4
o
C on the Eppendorf centrifuge 5810R. The supernatant was 
carefully discarded and tubes were raised on tissue paper to drain. The 
bacterial cell pellets were then washed three times with ice-cold 10% glycerol. 
Washing volumes were reduced each time. For the first wash, the two cell 
pellets were resuspended very gently in 100 mL of ice-cold 10% glycerol 
solution and harvested by centrifugation at 3000 rpm for 15 minutes at 4
o
C. 
Similarly, the two pellets were resuspended for a second wash in 50 mL of 
ice-cold 10% glycerol solution and harvested as above. This was followed by 
a third wash using 25 mL of ice-cold 10% glycerol solution. Cell suspensions 
were pooled into one 50 mL Falcon tube and harvested as above. The bacterial 
cell pellet was finally resuspended in 400 μL of ice-cold 10% glycerol 
solution. The bacterial suspension was distributed in 40 μL aliquots in ice-cold 
1.5 mL microcentrifuge tubes, which were then kept on ice for immediate 
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electroporation or quickly frozen in liquid nitrogen prior to storage at -80
o
C 





 apparatus was used for electroporation 
experiments. Briefly, 4.5 μL of a 20 μL purified ligation reaction was added to 
40 μL of cells suspension and mixed well by gentle pipetting. The cell/DNA 
mixture was left on ice for 5 to 10 minutes and carefully transferred to a 
prechilled 0.2 cm electrode gap Gene Pulser
®
 cuvettes. The cuvettes were 
tapped on the counter to insure all cells are at the bottom of the cuvettes. 
Before proceeding to electroporation, outside of the cuvette and inside of the 
electroporation chamber were ensure to be completely dry as any liquid would 
cause malfunction and electric shock. The cuvette was then placed in the 
chamber and subjected to one single pulse set to 2.5 kV, capacity 25 µF and 
resistance 200 Ω.  
After pulsing, the cuvette was removed from the chamber and 1 mL of 
cold SOC medium (Bioline, UK) or LB broth was immediately added to 
recover the cells. The cell suspension was resuspended quickly but gently and 
transferred to a 15 mL Falcon Blue tube. The tube was incubated at 37
o
C for 1 
hour with shaking at 250 rpm to allow the cells to begin expressing antibiotic 
resistance genes. The pulse parameters was also checked and recorded. The 
time constant should be close to 5 msec. Finally, 50 to 150 μL of the recovered 
bacterial culture were plated onto LB agar containing appropriate antibiotic 
and incubated overnight at 37
o
C. Transformants were counted to calculate the 





2.2.11. Mini preparation of plasmid DNA 
Single isolated EC100D pir+ E. coli transformant colony was 
inoculated in 5 mL of LB broth containing 50 µg/mL of kanamycin and 
incubated at 37
o
C with vigorous shaking overnight. Growth for more than 16 
hours is not recommended as cells begin to lyse and plasmid yields may be 
reduced. The overnight cultures were transferred to 1.5 mL microcentrifuge 
tubes and cells were harvested by centrifugation at 13000 rpm for 1 minute at 
room temperature. The supernatant was discarded and the open tubes were 
inverted to drain on tissue paper. Plasmid DNA was recovered and purified 
using the QIAprep
®
 Spin Miniprep Kit (Qiagen) as outlined in the 
manufactures’ instructions. All centrifugation steps were carried out at 13000 
rpm at room temperature.  
Briefly, each cells pellet was resuspended in 250 µL buffer P1 by 
pipetting up and down until no cell clumps visible. 250 µL of buffer P2 was 
then added and the solution was mixed thoroughly by gently inverting the tube 
to lyse the bacterial cells. The lysis reaction was not allowed to proceed more 
than 5 minutes. Next, 350 µL of buffer N3 was added to the mixture and 
mixed immediately and thoroughly by inverting 4 – 6 times to avoid localized 
precipitation. The tube containing cells mixture was centrifuged for 10 
minutes, and the supernatant was carefully removed and applied to the 
QIAprep spin column. The column was centrifuged for 1 minute and the flow-
through was discarded. As the EC100D
 
pir+ E. coli cells maintain the 
plasmids at approximately 15 copies per cell, the first wash step with buffer 
PB was required. 500 µL of buffer PB was added to the column and 
centrifuged for 1 minute. The flow-through was discarded and the column was 
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washed second time by applying 750 µL of buffer PE. The washing buffer PE 
was allowed to incubate on the column for up to 5 minutes before 
centrifugation for 1 minute to more efficiently remove any salt from the DNA. 
The flow-through was discarded and the column was centrifuged for an 
additional 1 minute to remove residual wash buffer. The column was then 
placed in a new clean 1.5 mL microcentrifuge tube and the bound DNA was 
eluted by adding 50 µL or 30 µL (for increased DNA concentration) of 
preheated to 70
o
C of EB buffer (10 mM Tris-Cl, pH 8.5) to the center of the 
membrane. The column was let to stand for up to 4 minutes then centrifuged 
for a final time of 1 minute. The purified plasmid DNA was stored at -20
o
C 
until required.  
 
2.2.12. Sequencing of DNA 
DNA sequencing was performed at the 1
st
 Base Pte Ltd, Singapore. 
Plasmid DNA samples were prepared at concentration of 50 to 100 ng per µL 
in a volume of 10 µL per reaction. All samples were sequenced in both 
forward and reverse directions. Each primer was prepared at a concentration of 
10 µM and in 5 µL per reaction. The primers for sequencing are listed in Table 
2.4 (Section 2.2.7).  
 
2.3. EZ-Tn5 transposon mutagenesis 
The EZ-Tn5 <R6Kγori/KAN-2> transposome Kit (Epicentre®, USA) 
was used to create random insertion of transposable element into chromosomal 
DNA of M. smegmatis. The EZ-Tn5 transposon contains an R6Kγ conditional 





) that make it useful for “rescue cloning” of the region of genomic DNA 
into which the transposon has been randomly inserted.  
 
Generation of M. smegmatis transposon mutants 
Transposon mutagenesis was performed by electroporation of 
electrocompetent M. smegmatis cells as described in Section 2.1.1. Briefly, 1 
µL of the EZ-Tn5 <R6Kγori/KAN-2> transposome (instead of plasmid DNA) 
was added into 200 µL of electrocompetent cells. Another tube containing 
electrocompetent cells only was also subjected to electroporation, as a 
negative control. After electroporation, cells were immediately covered with 1 
mL of 7H9 broth. The cells solution was transferred to a 50 mL Falcon tube 
containing 4 mL of 7H9 broth and incubated at 37
o
C with shaking for 3 hours 
to facilitate cell outgrowth. The cell solution was concentrated to 1.5 mL and 
each 100 µL of undiluted cells was plated separately on 15 7H10 agar plates 
containing 25 µg/mL of kanamycin. Plates were incubated at 37
o
C until 
colonies became visible (3-4 days). Transformants were counted to calculate 
the transformation efficiency.  
To prepare glycerol stocks of transposon mutants, single colony was 
picked and inoculated with 5 mL of 7H9 broth containing 25 µg/mL of 
kanamycin in a 50 mL Falcon tube. The tube was incubated at 37
o
C with 
shaking overnight. The growth of cells was monitored until the OD600 reached 
0.8 to 1.0. For each stock, 500 µL of cell cultures were mixed with 500 µL of 
50% glycerol in a screw-cap 2 mL tube. The tubes were labeled and glycerol 






Identification of transposon-disrupted gene by rescue cloning 
Genomic DNA from chosen clones were prepared as described 
(Section 2.2.2) and 2 to 3 µg of the genomic DNA were digested by restriction 
enzyme EcoRI, which does not cut within the transposon (Section 2.2.5). 
Fragmented genomic DNAs from digestion reaction were purified prior to 
performing the self-ligation (Section 2.2.8). The purified DNAs were self-
ligated using four different amounts of the DNA, including 100, 150, 200 and 
400 ng for checking the optimized amount of DNA required for an effective 
self-circularization (Section 2.2.6). The ligation products were again purified 
before introducing into electrocompetent EC100D pir
+
 E. coli cells by 





 E. coli cells. Another tube containing only 
electrocompetent cells was also subjected to electroporation, as a negative 
control (Section 2.2.10).  
The circularized fragments containing the transposon replicate as 
plasmids and the transformants were recovered on LB agar containing 50 
µg/mL of kanamycin. Cells were also plated on LB agar without antibiotics to 
check for viability after electroporation. All samples were plated in triplicates.  
The Kan
R
 colony was selected overnight and transposon junction 
plasmids were isolated (Section 2.2.11). Purified plasmid DNA was sequenced 
using the forward and reverse EZ-Tn5<R6Kγori/KAN-2> Transposon-specific 
primers KAN-2 FP and R6KAN-2 RP, which anneal to two ends of the 
transposon (Section 2.2.12 and Table 2.4).  
In addition, the plasmid pBSSK was used as a positive control for 
electroporation using self-ligation products. It was also digested, then self-
ligated and finally transformed into electrocompetent DH5α E. coli cells. The 
electroporated pBSSK/DH5α E. coli cells were plated on LB agar containing 
55 
 
100 µg/mL of ampicillin.  
An overview of the process for rescue cloning of the EZ-
Tn5<R6Kγori/KAN-2> Transposon insertion site in the genomic DNA was 











Figure 2.4. The process for rescue cloning of transposon insertion site in the 
genomic DNA using the EZ-Tn5<R6Kγori/KAN-2> Transposome and 
EC100D pir
+
 E. coli cells. 
 
DNA sequences were searched directly against the non-redundant 
database at NCBI (National Center for Biotechnology Information) using 
either BLASTN for a nucleotide search or BLASTX to search the protein 
database with translated nucleotide query.  
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3.1. Generation of M. smegmatis transposon mutants 
3.1.1. Optimization of M. smegmatis electroporation 
The number of transposition clones obtained using the transposome 
system is critically dependent on the transformation efficiency (TE) of the host 
cell. The higher the TE of the cell, the more clones will be produced. 
According to the EZ-Tn5 transposome manufacturer, the TE of 
electrocompetent cells should be about and above 10
7
 c.f.u/µg of DNA, but 
use cells of the highest TE possible is recommended to maximize the number 
of transposon insertion clones. Thus, electroporation of M. smegmatis was 
optimized using the plasmid pMV262 in attempts to obtain the highest TE 
possible prior to electroporating with the transposome. Basically, the 
electroporation procedure was performed as described in Goude and Parish 
(2009). However, preliminary electroporation experiments were unsuccessful 
as there were no colonies observed after 5 days incubation. This result could 
be due to main two reasons: (i) low time constant, only 6.9 msec while at least 
10 msec for M. smegmatis should be obtained; (ii) delay in initiating the cell 
recovery process, the electroporated cell suspensions that should be 
immediately recovered in medium after pulsing was incubated on ice for 
further 10 minutes. In addition, clumping was also observed during the 
washing steps when preparing electrocompetent cells.  
Thus, some minor modifications have been applied. Firstly, Tween 80 
was added into the washing solution to a final concentration of 0.5% (v/v) for 
preparation of electro-competent cells. Secondly, the cell pellets were 
resuspended carefully using filter tips in order to reduce clumping of 
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mycobacterial cells. Thirdly, the electroporated cells suspension was 
recovered in medium as soon as possible after pulsing to avoid losing 
transposed cells. Results of electroporation efficiency of both original and 
modified methods are represented in Table 3.1.  
 











Time constant (msec) 6.9 14.2 15.1 17.3 
Transformation efficiency (TE) 
(c.f.u/µg) 
N/A 9.8 x 103 1.9 x 105 4.2 x 106 
N/A: Not applicable as there were no colonies formed. 
As shown in Table 3.1 that there is a clear difference in electroporation 
efficiency of the original and the modified methods, both in time constant and 
TE. While the TE using the original method was considered as “zero” (i.e. no 
colonies formed), the TE using the modified method was increased after 
several attempts, from about 10
4
 c.f.u/µg in the 1
st
 attempt to approximate 10
7
 
c.f.u/µg in the 3
rd
 attempt. In addition, the time constant of all electroporation 
trials using the modified method were higher than 10 msec, which is the 
standard time constant for M. smegmatis. It appeared that the higher the time 
constant, the better the TE. Indeed, the 3
rd
 electroporation attempt showed the 




In general, the modified method was shown to deliver a successful 
electroporation of M. smegmatis using pMV262 with acceptable TE, which is 
approximate 10
7
c.f.u/µg. Thus, this method was used to perform the 
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transposon mutagenesis of M. smegmatis using the EZ-Tn5 <R6Kγori/KAN-
2> transposome. 
 
3.1.2. Transposon mutagenesis of M. smegmatis using the EZ-Tn5 
transposome 
To generate M. smegmatis transposon mutants, 200 µL of 
electrocompetent cells was electroporated with 1 µL of the EZ-Tn5 
<R6Kγori/KAN-2> transposome. A total of 1.2 x103 kanamycin-resistant 
single colonies were observed after 4 days incubation, making the TE of about 
3.6 x 10
4 
mutants per µg (Figure 3.1). Among the colonies, ten were randomly 
picked and inoculated with 7H9 broth containing 25 µg/mL of kanamycin to 
prepare the glycerol stocks for further analyses.  
 
  
Figure 3.1. M. smegmatis transposon mutants generated by electroporation 
with the EZ-Tn5 <R6Kγori/KAN-2> transposome 
Two out of 15 Middlebrook 7H10 plates containing M. smegmatis kanamycin-resistant 
colonies at day 4
th
 incubation are shown. Colonies are seen different in sizes, indicating 
transposon-disrupted genes affected to cell growth. As clumping were also observed, for 
example in plate 1.11 on the right (circles in red), only unique single colonies were 
counted for transformation efficiency.  
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In addition, in order to determine if the kanamycin resistance was due 
to the transposon insertion into the genome of the host cell and not merely to 
the acquired resistance, electroporation was also performed with cells in the 
absence of the DNA. The cell suspensions were plated onto Middlebrook 
7H10 agar containing 25 µg/mL of kanamycin, same as the concentration used 
for mixture of cell solution and the transposome. As expected, there were no 
colonies formed up to 5 days incubation. 
 
3.2. Optimization of isolation of M. smegmatis genomic DNA 
Since the genome of M. smegmatis was used as the main genetic 
material in experiments through the project, the isolation of high yield and 
good quality of the genomic DNA was important. The preparation of M. 
smegmatis genomic DNA from a small volume of cells culture (about 5-6 mL) 
used in experiments were adapted from the protocol as described in Belisle et 
al. (2009) with modifications in order to achieve higher yield and better 
quality of the DNA. Table 3.2 represents the major changes in procedures 
between the original and optimized methods as well as the concentration and 
purity of the DNA that were measured by a spectrophotometer.  
 
Table 3.2. Main differences in the preparation of mycobacterial genomic 






Method 1 Method 2 Method 3 
Lysozyme addition (1mg/mL) No  Yes No Yes 
SDS concentration (%) 1 1 4 4 
No. Chloroform: isoamyl extraction step  1 1 2 2 
A260/A280 ratio  2.05 2.01 1.96 1.89 




Among changes applied to the original method, the two main 
differences are the addition of lysozyme to a final concentration of 1 mg/mL 
with 2 hours incubation at 37
o
C, and the increase in concentration of SDS 
from 1% to 4%. Three methods were made up from the combination of these 
changes, including: (i) addition of lysozyme; (ii) increase in SDS 
concentration; and (iii) both addition of lysozyme and increase in SDS 
concentration. As shown in Table 3.2, all four methods gave different results 
in genomic DNA yields.  
The DNA concentration isolated using Method 1 and 3 (more than 250 
ng/µL) was higher than that of using the original and Method 2 (less than 80 
ng/µL). The original method gave the lowest concentration of isolated DNA, 
68.6 ng/µL, whereas the Method 3 gave the highest concentration, 292.6 
ng/µL, which is approximate 4 times higher.  
It can be seen from these results that the difference in DNA yields 
obtained between methods was mainly due to the addition of lysozyme. 
Indeed, the amount of DNA isolated using the original method has increased 
dramatically from 68.6 ng/µL to 252.6 ng/µL with the addition of lysozyme 
only, i.e. Method 1.  
On the other hand, the change in SDS concentration per se (i.e. 
Method 2) contributed a small increase in DNA yield, from 68.6 ng/µL for the 
original method to 76.6 ng/µL for Method 2. Similarly, the DNA yields 
obtained from Method 1 and 3 that both of them had addition of lysozyme but 
different in concentration of SDS are 252.6 and 292.6 ng/µL, respectively.  
The purity of the DNA is determined by the A260/A280 ratio. While an 
absorbance ratio of 1.7 to 2.0 is considered acceptable, that of greater than 2.0 
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indicates contamination with protein. The table 3.2 shows that the A260/A280 
ratio of Method 2 and 3 (1.96 and 1.89, respectively) was below 2.0 compared 
to that of the original and Method 1 (2.05 and 2.01, respectively). Therefore, it 
can be noted that the DNAs obtained from Method 2 and 3 have higher purity 
than that of the original method and Method 1. This could be because of the 
additional chloroform/isoamyl alcohol extraction step that resulted in better 
removal of proteins from solution. The quality of isolated DNA was also 
examined by agarose gel electrophoresis (Figure 3.2).  
 
        
Figure 3.2. Agarose gel electrophoresis of M. smegmatis genomic DNA 
isolated using original and optimized methods. 
(O: Original method; Lane 1-3: Method 1, 2, 3 and M: DNA ladder) 
Left: Same volume (2 µL) of DNA samples from each method were loaded. Right: Same 
amount (about 500 ng) of DNA samples from each method were loaded.  
 
Figure 3.2 shows the agarose gel electrophoresis results of M. 
smegmatis genomic DNA isolated using original and optimized methods, in 
same volume loaded (gel picture on the left) and in same amount loaded (gel 
picture on the right). In both analyses, clear bright bands were only observed 
in samples of Method 1 and 3. Fluorescence was also seen at the wells for 
   M      O       1        2        3      M    M     O       1       2       3      M 
  Genomic DNA 
  3 kb   3 kb 
  Genomic DNA 
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sample of Method 1 in both gel pictures. This could be because the DNA was 
extracted with only one round of organic solvent and had high A260/A280 ratio 
(Table 3.2), suggesting the possible presence of contamination with proteins. 
The samples of the original and Method 2 just showed very light bands when 
the amount of DNA loaded was increased from about 150 ng (in 2 µL of 
volume) to 500 ng.  
The agarose gel analysis also revealed that the DNA concentration 
measured by the NanoDropT1000 spectrophotometer was not fully accurate. It 
is because the intensities of bands from all samples were lower than that of the 
DNA marker, i.e. the 3 kb band. While the amount of samples used was up to 
500 ng (gel pic on the right), the amount of the reference band marker was 
only 70 ng. Nevertheless, both measurement by the spectrophotometer and 
analysis by agarose gel electrophoresis showed similar results regarding to the 
effectiveness of each method.  
In conclusion, the optimized method No.3 that include the addition of 
lysozyme, the increase in concentration of SDS, and a second organic 
extraction step gave the highest yield and the best quality of obtained DNA 
among methods. Therefore, this method was used for preparation of M. 
smegmatis genomic DNA in this study.  
 To further check the quality of the isolated genomic DNA for further 
analyses and also to confirm the identity of M. smegmatis, a 1000 bp sequence 
of the upstream region of Ms-fadB2 was PCR amplified using genomic DNA 
samples of all four methods as templates (Table 2.4 for primers). PCR 
products monitored by agarose gel electrophoresis showed clear distinct bands 
at correct size for all methods (Figure 3.3). 
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Figure 3.3. Identity confirmation of M. 
smegmatis by PCR amplification 
 
(O: Original method; Lane1-3: Method 1, 2, 3; 
C: Negative control; and M: DNA ladder) 
A 1000 bp sequence of the upstream region of 
Ms-fadB2 was PCR amplified using genomic 
DNA samples of all four methods. 
 
3.3. Confirmation of the presence of transposon insertion in bacterial 
genome 
 In order to ensure that resistance to kanamycin was due to insertion of 
the Tn903 Kan
R
 gene contained within the EZ-Tn5 <R6Kγori/KAN-2> 
transposon in the genome of M. smegmatis, PCR amplification was performed 
using primers KanR-FP and KanR-RP (Table 2.4) specific for the Kan
R
 gene 
in its entirety. In all M. smegmatis transposon mutants that were tested, a PCR 
product of 816 bp would be expected. The pR6Kan and pJV53 plasmids, 
which contain the Kan
R
 gene, were used as positive controls. The genome of 
M. smegmatis wild type was also examined as a negative control. PCR 
products monitored by agarose gel electrophoresis showed clear bands of 
approximate 800 bp in all tested mutants, but the wild type (Figure 3.5). This 
result confirmed the insertion of the transposon in M. smegmatis genome.   
 Prior to checking for the presence of the Kan
R
 gene, genomic DNA of 
seven randomly selected mutants was examined by agarose gel 
electrophoresis, and PCR amplified for the upstream region of Ms-fadB2 as 
mentioned above to confirm the identification as M. smegmatis. The migration 
of genomic DNA of mutants in the gel was similar to that of the wild type, and 
   M    O     1    2    3    C    M 
  3000 bp 




PCR products of all mutant samples and wild type showed distinct bands at 
1000 bp as expected (Figure 3.4). 
 
    
Figure 3.4. Agarose gel electrophoresis of genomic DNA of M. smegmatis 
transposon mutants and wild type 
Lane 1-7: mutants; WT: wild type; C: negative control; and M: DNA ladder. 
Left: Comparison of isolated genomic DNA of seven representative M. smegmatis EZ-
Tn5 <R6Kγori/KAN-2> mutants and wild type. Right: Identity of M. smegmatis 
transposon mutants and wild type was confirmed by PCR amplification of a 1000 bp 
sequence of the upstream region of Ms-fadB2 of M. smegmatis 
 
 
Figure 3.5. Confirmation of the presence of transposon insertion in genome of 




Lane 1-7: mutants; WT: wild type; C: negative control; P1: positive control (pR6Kan); 
P2: positive control (pJV53); and M: DNA ladder). 
The inserted transposon <R6Kγori/KAN-2>, represented by an 816 bp of Kan
R
 gene, was 
detectable by PCR in all mutants, but the wild type.  
 
M      1        2        3        4        5        6        7      WT    M  M      1       2       3       4       5      6      7      WT     C    M 









3.4. Confirmation of the single and random insertion by Southern 
hybridization 
 To exclude that the transposon inserted into the bacterial chromosome 
multiple times, genomic DNA from ten randomly selected transposon mutants 
was prepared and analyzed via Southern hybridization. The extracted DNA 
was digested to completion with EcoRI and probed with the DIG-labeled 
Kan
R
. The plasmid pR6Kan containing the Kan
R
 gene and the pBSSK 
containing the ampicillin resistance gene (Amp
R
) were used as positive and 
negative controls, respectively. Results showed that none of the isolated 
genomic DNA contained more than one hybridizing DNA fragment, indicating 
that each Kan
R
 colony contains only a single insertion. Furthermore, the 
hybridizing bands were located at different sizes on the blot. This 
demonstrates that insertion sites were randomly distributed in the chromosome 











Figure 3.6. Southern hybridization analysis showing random insertion of the EZ-Tn5 
<R6Kγori/KAN-2> transposon in the chromosome of M. smegmatis 
 
Lane 1-10: mutants; WT: wild type; P: positive control (pR6Kan); N: negative control (pBSSK); and M: 
DNA ladder). 
Upper part: Chromosomal DNA from M. smegmatis wild type and ten randomly selected M. smegmatis 
transposon mutants was digested with EcoRI, which does not cleave within the transposon. The fragments 
were separated on a 0.8% agarose gel.  
Lower part: The DNAs were then probed with the DIG-labelled Kan
R 
gene. The probe-target hybrids 
were detected by enzyme-linked immunoassay using anti-DIG-alkaline phosphatase, and followed by 
incubation with NBT/BCIP for color development. The Kan
R 
gene-carrying plasmid pR6Kan was used as a 
positive control. Genomic DNA of M. smegmatis wild type not subjected to transposon mutagenesis and 
the Amp
R
 gene-carrying plasmid pBSSK were used as negative controls. The blot shows that each of the 
kanamycin-resistant colonies contained a single insertion as only one hybridizing band was detected per 
lane. However, there was no a clear band detected in lane of mutant 10. This could be because the DNA 
was degraded while processing.  
As the amount of plasmid DNA loaded to gel was high (about 100 ng), the intensity of the band for 
pR6Kan, the positive control, was markedly high. The color precipitate was even leaked to the lane of the 
wild type. The lanes of the negative controls, pBSSK and M. smegmatis wild type did not show any bands, 
as expected. Although the DNA ladder was not labelled for visualization of markers, all hybridizing bands 
were at different sizes on the blot. This demonstrates that the insertion of transposon randomly occurred at 
different places on the chromosome. 
 










3.5. Identification of transposon-disrupted gene by rescue cloning 
 Since the EZ-Tn5 <R6Kγori/KAN-2> transposon contains an R6Kγ 
conditional origin of replication (R6Kγori), the sequence of the DNA flanking 
the inserted transposon can be obtained by the use of “rescue cloning” (Kirby, 
2007). The rescue cloning process includes the following main points. Firstly, 
the genomic DNA is cleaved with a restriction enzyme that does not cut within 
the insert or cuts only once, but leaves the origin of replication and selectable 
marker gene intact. Secondly, the fragmented DNAs are self-ligated to 
produce rescue plasmids from the vicinity of transposons. The mixture of 
random genomic circles is finally transformed into a pir E. coli strain. When 
selected on kanamycin-containing plates, only molecules that carry the 
R6Kγori and flanking chromosomal DNA can replicate, allowing the cells that 
contain the <R6Kγori/KAN-2> transposon to grow. Plasmids isolated from 
these cells can be sequenced using primers specific to the 3’ and 5’ ends of the 
transposon that outwardly direct the sequencing reactions into the 
chromosomal DNA (Figure 3.7 for schematic diagram of the EZ-Tn5 
<R6Kγori/KAN-2> transposon). Thus, the gene disrupted by the insertion of 
the transposon would be identified (Kirby, 2007).  
 
Figure 3.7. Schematic diagram of the EZ-Tn5 <R6Kγori/KAN-2> transposon 
(Kirby, 2007) 
The transposon contains an R6Kγ conditional origin of replication (R6Kγori) for 
replication in the pir cloning strain, and the Tn903 kanamycin resistance gene (Kan
R
) for 
growth selection. They are flanked by two hyperactive 19-bp Mosaic Ends (MEs) EZ-Tn5 
Transposase recognition sequences. The transposon-specific forward and reverse primers 
(FP and RP) that bind to two ends of the transposon outwardly direct the sequencing 
reactions into the chromosomal DNA. 
 
In this study, a trial analysis of identifying the transposon-disrupted 
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genes was carried out with three randomly chosen M. smegmatis Kan
R
 
colonies as described in Chapter 2, Section 2.3. Briefly, genomic DNA was 
prepared from the mutants and digested with the restriction enzyme EcoRI. 
The fragmented genomic DNA was self-ligated using four different amounts 
of DNA, including 100, 150, 200 and 400 ng to check for the optimized 
amount of DNA required for an effective self-circularization. The ligation 
products were then used to transform into the electrocompetent EC100D pir
+
 
E. coli cells by electroporation. The cells were recovered and plated on LB 
agar containing 50 µg/mL of kanamycin. The Kan
R
 colony was selected 
overnight and transposon junction plasmids were isolated. Purified plasmid 
DNA was sequenced using transposon-specific primers KAN-2 FP and 










Figure 2.4. The process for rescue cloning of transposon insertion site in the 
genomic DNA using the EZ-Tn5<R6Kγori/KAN-2> Transposome and 
EC100D pir
+
 E. coli cells. 
Purify and digest genomic 
DNA with EcoRI 
<R6Kγori/KAN-2> clone 
Rescued plasmid DNA Kan
R




 E. coli 
and select on Kan plates 
EcoRI 
<R6Kγori/KAN-2> 
KAN-2 FP primer 
Sequence junctions to 
identify site of insertion 
R6KAN-2 RP primer 
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 Results of the trial analysis showed that among three tested mutants, 
only the transposon-carrying plasmid of Mutant 1 was successfully rescued. 
After selection with kanamycin overnight, no colonies were observed in all 
plates assigned for three mutants. The only exception is one single colony 
appeared on the plate placed with cells that were transformed with ligation 
products of Mutant 1. The results of cell transformation are shown in Table 
3.3.  
Table 3.3. Electroporation efficiency of cells transformed with self-ligation 
products 
 
Number of colonies obtained from plates after antibiotics selection overnight 
Amount of DNA 
used in ligation 
reactions (ng) 
Cells + DNA 
Mutant 1 
Cells + DNA 
Mutant 2 






Cells only  




150 N N N 75 
200 N N N 
 400 1 N N 
   
      Transformation 
efficiency (c.f.u/µg) 
   
1.5 x 107 1.4 x 103 
  
(†) Plasmid pR6Kan was not subjected to the self-ligation reaction, used as positive control 
for electroporation of EC100D pir+ E. coli cells, 1 µL (10 pg) of plasmid was used. 
(*) Plasmid pBSSK was digested then ligated, used as positive control for electroporation of 
DH5α E. coli cells using self-ligation products, 4.5 µL (~53 pg) of purified ligation products 
was used. 
N: No colonies were observed.  
 
 Table 3.3 shows that the electroporations of the EC100D pir
+
 E. coli 
cells using the ligation products of three mutants were not effective as there 
was only one colony formed for Mutant 1, and none for Mutant 2 and 3. More 
interestingly, only cells were transformed with ligation products using 400 ng 




Electroporation of the EC100D pir
+
 E. coli cells using pR6Kan, which 
was used as a positive control, gave a TE of 1.5 x 10
7
 c.f.u/µg. This TE is 
lower than that of the reference, which is 5 x 10
9
 c.f.u/µg (according to 
manufacturer’s recommendation).  
Four different amounts of fragmented genomic DNA of the mutants 
that had been tried in the ligation reactions seemed not able to promote an 
effective self-circularization. It resulted in no appearance of colonies after 
kanamycin selection overnight of the transformed cells, except only one 
colony for Mutant 1. The plasmid pBSSK was used as positive control for 
electroporation of cells using self-ligation products. For the ligation reaction, 
150 ng of digested pBSSK was used. Electroporation of DH5α E. coli cells 
using the purified ligation products gave a TE of 1.4 x 10
3
 c.f.u/µg, 
demonstrating the reactions worked.  
Moreover, no colonies were formed in plates that cells were 
electroporated without addition of DNA, indicating the antibiotic resistance 
was not due to acquired resistance. On the other hand, a bacterial lawn was 
observed in LB agar without antibiotics. This shows that cells were alive after 
electroporation. 
 Plasmid DNA was prepared from the obtained colony, and digested 
with either EcoRI to check for its size or HindIII to confirm the presence of 
the EZ-Tn5<R6Kγori/KAN-2> transposon as this restriction enzyme cuts the 
transposon twice at location 416 and 1969, generating a fragment of about 










Figure 3.8. Restriction digestion of 
transposon Mutant 1-generated plasmid.  
 
(Lane: 1- Uncut; 2- Cut with EcoRI; 3- Cut with 
HindIII, M: DNA ladder) 
Digestion with EcoRI revealed only one band, 
showing the size of the plasmid that is considered 
large, and more than 10 kb.  
Digestion with HindIII gave two bands with the 
small one at about 1500 bp, indicating the presence 
of the transposon in the plasmid.  
  
Plasmid sequencing allowed the determination of the DNA sequences 
flanking the insertion site. The sequences were subjected to a BLAST 
homology search against the non-redundant nucleic acid (BLASTN) and 
protein (BLASTX) databases. The blasting results revealed that the 
transposon-disrupted gene in the M. smegmatis Mutant 1 was identified as 
pntB (Gene ID 4537525) at locus MSMEG_0109 with more than 93% in 
identity for both forward and reverse sequences. This gene encodes the protein 
NAD(P) transhydrogenase beta subunit (accession no. YP_884525).  
The sequencing results also showed the presence of 9-bp target 
duplications in the mutant DNA flanking the EZ-Tn5 transposon at the Mosaic 
End (ME) right and left, which is a unique characteristic of the Tn5 insertion 
(Goryshin et al., 2000). Thus, this confirms that transposition of the 

















<R6Kγori/Kan-2> sequence:                                              CTGTCTCT < R6Kori/Kan-2> AGAGACAG 
Reverse sequence… CCCACGAATGGACAGGATGTAGACAGAGA                            AGAGACAGGTCCTACATCATGTGCAAGGC… Forward sequence  
                             (... CCCAGCAATGGACAGGATGTA                                                                          CAGGATGTAGTACACGTTCCG…) 
pntB sequence:    ... CCCAGCAATGGA                                                                                                                               GTACACGTTCCG…                                      
 
Figure 3.9. Mapping of transposon insertion and confirmation of Tn5 transposition in M. smegmatis transposon Mutant 1 
 
Sequencing reactions used the transposon-specific primers KAN-2 FP and R6KAN-2 RP that read from two ends of the transposon. 
The junctions between the transposon sequence and the genomic DNA sequence, which are the 8-bp of the Tn5 inverted repeats, are shown in red. The 9-bp 
duplications in the mutant DNA flanking the ME right and left ends are shown in blue. 
The forward and reverse sequences are also compared with pntB sequence. The gene is 1443 bp in length and located at position from 132711 to 134153 
(complement) of the genome of M. smegmatis mc
2
 155 (accession no. NC_008596.1). The BLAST results also showed that the insertion of transposon was at 
the middle of the gene. 






4.1. Isolation of mycobacterial genomic DNA  
 In general, the preparation of genomic DNA from bacteria involves 
three main steps: (i) disruption of the bacterial cell; (ii) extraction of the DNA 
using organic solvents; and (iii) recovery of the DNA by alcohol precipitation. 
Among them, cells disruption is considered as the most difficult and uncertain 
step. The difficulties are more enhanced in bacteria such as Mycobacterium 
spp. that are highly resistant to cell disruption due to their unusual thick waxy 
cell wall (Moore et al., 2004).  
The most common and desirable way to lyse the bacteria is through 
enzymatic degradation and detergent treatments of the cell wall. Lysozyme 
and proteinase K are two most commonly used enzymes for the disruption of 
bacterial cells. The enzyme lysozyme causes damages by catalyzing the 
hydrolysis of the linkage between N-acetylmuramic acid and N-
acetylglucosamine residues in the peptidoglycan layer of the bacterial cell 
walls. The effectiveness in disrupting bacterial cells by lysozyme is increased 
in the presence of a metal chelating agent, for example, EDTA. EDTA binds 




, resulting in a decrease of the 
stabilities of the wall and membranes (Moore et al., 2004). 
The enzyme proteinase K acts in cell disruption by cleaving the 
peptide bond adjacent to the carboxyl groups of aliphatic and aromatic amino 
acids. These bonds form crosslinking bridges of the peptidoglycan layers of 
the bacterial cell walls. This ability of proteinase K is also increased with 
addition of chelating agents, allowing it to be used in combination with EDTA 
and lysozyme (Moore et al., 2004).  
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Treatments with detergents such as SDS and CTAB also contribute to 
the disruption of bacterial cells. The use of CTAB is more applicable to 
mycobacteria in terms of removing the contaminating polysaccharides that are 
abundant in the species (Belisle et al., 2009). Detergents are shown to be 
particularly effective when the cell walls have been treated with metal 
chelating agent and enzymes (i.e. EDTA, lysozyme, proteinase K) before their 
addition to the cell suspension.  
In addition to enzymatic degradation and detergent treatments, other 
protocols employing mechanical disruption such as beads beater or French 
pressing have been applied to bacteria whose cell walls are difficult to lyse. 
Although the mechanical disruption has been shown effectively for 
mycobacterial cell lysis, the disadvantage of this technique is the generation of 
sheared genomic DNA (Belisle et al., 2009).  
As the genome integrity is important in further analysis of the 
transposon mutants, i.e. Southern blot analysis, only enzyme-detergents 
treatments were used for the isolation of mycobacterial genomic DNA in this 
study. The small-scale preparation of M. smegmatis genomic DNA used in the 
study was a modification of the protocol developed by Belisle et al. (2009). 
This method employs only proteinase K, SDS and CTAB for disruption of the 
bacterial cells. The addition of lysozyme in the optimized method showed a 
considerably increase of more than 250% in the DNA yield compared to that 
of using the original protocol, i.e. from 68.6 ng/µL to 252.6 ng/µL.  
An increase in the concentration of SDS was adapted from Kaser et al. 
(2009 and 2010). The incubation with 4% SDS followed by a mechanical 
disruption has resulted in significant increasing DNA yields (Kaser et al., 
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2009). However, experiments showed that there were only slight increases in 
DNA yields obtained from optimized methods using higher concentration of 
SDS either without or with addition of lysozyme, about 11% and 15%, 
respectively. This could be because the increase in the concentration of SDS 
was not followed by a mechanical disruption as mentioned in the reference 
protocol. In summary, regardless of the large or small scale, lysozyme 
treatment plays an important role in the isolation of genomic DNA from 
mycobacteria because of its high effectiveness in disrupting the bacterial cell 
wall.  
4.2. Transposon mutagenesis of M. smegmatis using the EZ-Tn5 
transposome 
 Electroporation of 1 µL of the EZ-Tn5 <R6Kγori/KAN-2> 
transposome into M. smegmatis generated approximate 1.2 x10
3
 single 
kanamycin-resistant colonies. As “clumping” of colonies was also observed on 
many plates, higher dilution of cell solutions prior to plating is expected to 
reduce clumping and result in more single colonies. This result is considered 
acceptable in comparison with that of the manufacturer’s reference (1-5 x102 
colonies) and other studies, in which the EZ-Tn5 transposome was also used 





were observed in Flores et al. (2005) and Maus et al. (2005), respectively. 
The resistance to kanamycin, which is due to insertion of the Kan
R
 
gene contained within the transposon in the genome of the bacteria, was 
confirmed by PCR amplification of Kan
R
 gene. In all randomly chosen M. 
smegmatis transposon mutants that were tested, the agarose gel electrophoresis 





 gene that is 816 bp in size. In addition, the Southern 
hybridization analysis using labeled Kan
R
 gene as a probe has proven that the 
transposon inserted only once per mutant clone (colony) and that it was 
randomly distributed in the chromosome. Indeed, none of the genomic DNA 
isolated from ten randomly selected M. smegmatis mutants contained more 
than one hybridizing DNA fragment, indicating that each Kan
R
 colony 
contained only a single insertion. Furthermore, differences in sizes of the 
hybridizing bands on the blot demonstrated random insertion of the 
transposon. Similar results confirming this characteristic of the EZ-Tn5 
transposon were also observed in either M. smegmatis (Derbyshire et al., 
2000) or other species (Goryshin et al., 2000; Fernandes et al., 2001; Riess et 
al., 2003).  
Identification of transposon-disrupted genes were carried out using the 
rescue cloning method, in which genomic DNA of the transposon mutant is 
digested by restriction enzyme(s) that do not cleave within the transposon and 
then self-ligated to generate rescue plasmids from the vicinity of the 
transposon. Plasmids isolated can be sequenced using primers specific to two 
ends of the transposon that outwardly direct the sequencing reactions into the 
chromosomal DNA. Thus, the DNA sequences flanking the insertion site 
would be determined.  
However, the trial analysis of three selected mutants showed that the 
rescue cloning was successful for only one mutant. This is because after 
selection with antibiotic overnight of E. coli cells transformed with self-
ligation products, colony was formed only for Mutant 1 and none for Mutant 2 
and 3. This could be possibly due to the large size of plasmids containing the 
77 
 
transposon. Prior to electroporation into the cells, the ligation products were 
purified using the QIAquick
®
 PCR Purification Kit. The kit might purify the 
large fragments if they are only a few kb larger than the 10 kb limit. 
Restriction digestion of the isolated transposon Mutant 1-plasmid 
revealed that its size was more than 10 kb (see Chapter 3, Figure 3.8), and the 
Southern blot results also showed that the DNA fragments containing the 
transposon of Mutant 2 and 3 were even larger than that of Mutant 1 (see 
Chapter 3, Figure 3.6). Therefore, their large sizes could result in an inefficient 
purification of ligation products, leading to unsuccessful transformation 
observed for Mutant 2 and 3. In order to improve purification efficiency of the 
re-ligation products, it is suggested that the genomic DNA should be digested 
with a combination of multiple restriction enzymes, instead of a single one. 
This might reduce the size of DNA fragments that contain the transposon, 
allowing a higher efficient purification of circular DNA molecules after self-
ligating. As a result, the transformation efficiency of self-ligation products 
containing the transposon into E. coli would be also improved. The methods 
employing two restriction enzymes for digestion of the mutant genomic DNA 
have been used in several studies (Fernandes et al., 2001; Guerra-Lopez et al., 
2007; Viti et al., 2009). In addition to the rescue cloning, other methods have 
been developed to map the insertion sites, including the direct sequencing of 
the genomic DNA (Hoffman et al., 2000; Riess et al., 2003) and a number of 
optimized PCR techniques (Laurent et al., 2003; Jacobs et al., 2003; Levano-
Garcia et al., 2005; Veeranagouda et al., 2012).  
Among transposon mutagenesis techniques, the EZ-Tn5 transposome 
system has been shown to provide several advantages that make it a simple 
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and efficient tool for generating a library of random gene knockouts in vivo for 
mycobacteria. The transposome can be easily introduced into cells by 
electroporation and all insertion events are independent. This system also does 
not require suicide vectors such as suicide plasmids or phage for delivery. The 
drawback of these suicide vectors is that they encode both transposon and a 
transposase, which might cause instability of the transposon within the 
genome. On the other hand, the EZ-Tn5 transposome makes the transposon 
stable once it is inserted into the host genome since the transposase is made 
separately and does not survive cell division (Hoffman, 2011). 
 
4.3. Transposon-disrupted gene, pntB 
 The BLAST results showed that the M. smegmatis Mutant 1 has an 
insertion in the pntB gene, whose product is NAD(P) transhydrogenase beta 
subunit. This protein belongs to a group of transhydrogenases that are found in 
inner mitochondrial membrane of mammalian cells and in the plasma 
membrane of many bacteria. The enzyme catalyzes the reversible transfer of 
hydride-ion equivalents between NAD(H) and NADP(H) and is couple to the 
translocation of protons across the membrane (Wilson et al., 2006). The 







 + NADPH + H
+
in (Eq. I) 
The “in” and “out” indicate the cytoplasm and the periplasmic space, 
respectively, of bacteria or the matrix and the inter-membrane space, 
respectively, of mitochondria (Anderlund et al., 1999). The coenzymes NAD 
and NADP have important roles as cofactors in oxidation-reduction reactions 







because of the positive charge on the nitrogen atom in the nicotinamide ring, 
and the reduced forms are referred to as NADH and NADPH. These 
coenzymes have different roles in metabolism. While NAD
+
 is involved as a 
cofactor in energy-producing oxidation reactions, NADPH produced by 
transhydrogenases is used as a cofactor in reductive biosynthetic reactions 
(Sauer et al., 2004).  
According to the TB Database, pntB gene is highly conversed among 
Mycobacterium spp. and other species (Figure 4.1). This gene even has three 
homologues in M. smegmatis at three loci including MSMEG 0109, 0150 and 
4108. A search for PubMed and Google Scholar using the keywords, i.e. M. 
smegmatis and pntB or MSMEG 0109, 0150 and 4108, showed no results. It 
indicates that this gene has not been involved in any studies of M. smegmatis. 
Thus, this study reports the first time pntB as non-essential gene of in M. 
smegmatis. 
In M. tuberculosis H37v, pntB is located at the locus Rv0157 and 
functions in the central intermediary metabolism (Cole et al., 1998). Apart 
from NAD(P) transhydrogenase activity, the protein encoded by pntB has been 
identified in the membrane fraction of M. tuberculosis H37v as either 
predicted plasma membrane protein (Gu et al., 2003) or predicted integral 
membrane protein (Xiong et al., 2005). In a recent study, however, this protein 
has been shown its presence in the whole cell lysates, but not the membrane 
protein fraction or culture filtrate of M. tuberculosis H37v (de Souza et al., 
2011). High-density transposon mutagenesis using the Himar1-based 
transposon has also identified pntB as non-essential gene for optimal in vitro 
growth of M. tuberculosis H37v (Sassetti et al., 2003; Griffin et al., 2011).  
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Figure 4.1. The distance tree of the NAD(P) transhydrogenase pntB gene 
family 





4.4. Concluding remarks and future work 
 A transposon mutagenesis method for M. smegmatis has been 




system. Electroporation of 1 µL of 
the EZ-Tn5 <R6Kγori/KAN-2> transposome into the bacteria generated a 
total of 1.2 x10
3
 single kanamycin-resistant colonies. This result is acceptable 
in comparison with that of the manufacturer’s reference and literature. The 
resistance to kanamycin, which is due to insertion of the Kan
R
 gene contained 
within the transposon in the genome of the bacteria, was confirmed by PCR 
amplification of this gene in all randomly tested M. smegmatis transposon 
mutants. The Southern hybridization analysis using labeled Kan
R
 gene as a 
probe has also proven that the transposon inserted only once per mutant and 
that it was randomly distributed in the genome. 
  The rescue cloning method was successful to locate the transposon 
insertion site in the genome of one among three tested mutants. The 
transposon-disrupted gene in this mutant was identified as pntB, which is 
located at the locus MSMEG_0109. It has been shown that the pntB gene is 
highly conversed among Mycobacterium spp. and other species. However, this 
gene has not been involved in any studies of M. smegmatis based on a search 
for PubMed and Google Scholar. Therefore, this is the first report of pntB as a 
non-essential gene in M. smegmatis. It is suggested that this transposon mutant 
strain can be used to study dormancy, i.e. the non-growing or non-replicating 
state, of the bacteria that finally results in a latent infection (see Section 1.1). 
The two popular in vitro culture models employed to study the dormant state 
of mycobacteria are based on oxygen and nutrient starvation, respectively. 
These can be either oxygen depletion in nutrient-rich medium (Wayne model) 
or nutrient deprivation in oxygen-rich medium (Loebel model) (Dick, 1998 & 
Gengenbacher, 2010).  
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 In conclusion, transposon mutagenesis of M. smegmatis by the EZ-Tn5 
transposome technology is a simple and efficient method to obtain the 
transposon mutants. The established method described herein can be applied 
to generate large libraries of random gene knockouts in vivo of M. smegmatis, 
and other Mycobacterium species such as M. bovis BCG and M. abscessus, for 
future phenotypic screening. The Phenotype MicroArrays (PMs), developed 
by Biolog, Inc. (USA), provide an analogous two-dimensional array 
technology for analysis of live cells (phenomics) to quantitatively measure 
hundreds or thousands of cellular phenotypes all at once (Bochner, 2001). 
Biolog PM is a live-cell assay for nutritional research studies. The assay 
quickly reveals metabolic substrate preferences of cells, the rates of 
metabolism for each substrate as well as the metabolic sensitivity of cells to 
multiple chemicals (ions, pH, hormones, osmotic, and anti-microbial agents). 
The metabolic phenotyping assays that have been developed for quantifying 
and differentiating the energy flux (NADH generation) contain hundreds of 
metabolic substrates and chemicals. Each of the different carbon, nitrogen, 
phosphorus and sulphur metabolic substrates has been selected to enable 
precise energy measurements of a different metabolic pathway. Energy 
generation is determined using a proprietary redox dye that measures level of 
NADH generation. In addition, the chemical sensitivity assays provide more 
than two hundreds different anti-microbial agents. Thus, the results generated 
can be used to help target validation (determining functions of important 
genes), target identification (evaluating new drug candidate) and lead 
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